GlucoTrack (GCTK) 10-K 28 Mar 14 2013 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
	Dec. 31, 2013	Mar. 28, 2014	22-May-13
Document and Entity Information [Abstract]	'	'	'
Document Type	'10-K	'	'
Amendment Flag	'false	'	'
Document Period End Date	31-Dec-13	'	'
Entity Registrant Name	'Integrity Applications, Inc.	'	'
Entity Central Index Key	'0001506983	'	'
Current Fiscal Year End Date	'--12-31	'	'
Document Fiscal Year Focus	'2013	'	'
Document Fiscal Period Focus	'FY	'	'
Entity Filer Category	'Smaller Reporting Company	'	'
Entity Common Stock, Shares Outstanding	'	5,304,082	'
Entity Current Reporting Status	'Yes	'	'
Entity Well-known Seasoned Issuer	'No	'	'
Entity Voluntary Filers	'No	'	'
Entity Public Float	'	'	$42,798,070

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Dec. 31, 2013	Dec. 31, 2012
Current Assets	'	'
Cash and cash equivalents	$2,385,911	$543,411
Other current assets (Note 3)	93,052	81,472
Total current assets	2,478,963	624,883
Property and Equipment, Net (Note 4)	107,209	70,200
Funds in Respect of Employee Rights Upon Retirement	170,033	119,488
Total assets	2,756,205	814,571
Current Liabilities	'	'
Credit from banking institutions	'	37,427
Accounts payable (Note 5)	49,787	122,537
Other current liabilities (Note 6)	261,120	297,989
Total current liabilities	310,907	457,953
Long-Term Liabilities	'	'
Long-Term Loans from Stockholders (Note 8)	693,092	630,575
Liability for Employee Rights Upon Retirement (Note 2H)	236,074	229,112
Warrants with Down-Round Protection (Note 10M)	8,216,705	'
Total long-term liabilities	9,145,871	859,687
Total liabilities	9,456,778	1,317,640
Commitments and Contingent Liabilities (Note 9)	'	'
Temporary Equity	'	'
Convertible Preferred Stock of $ 0.001 par value ("Preferred Stock"): 10,000,000 shares authorized as of December 31, 2013 and December 31, 2012, respectively; issued and outstanding 7,417 shares as of December 31, 2013 and 0 shares as of December 31, 2012	4,362,545	'
Stockholders' Deficit	'	'
Common Stock of $ 0.001 par value ("Common Stock"): 40,000,000 shares authorized as of December 31, 2013 and December 31, 2012; issued and outstanding 5,301,693 shares and 5,460,600 shares as of December 31, 2013 and December 31, 2012, respectively	5,302	5,461
Additional paid in capital	14,532,068	14,772,371
Accumulated other comprehensive income	52,702	8,925
Deficit accumulated during the development stage	-25,653,190	-15,289,826
Total stockholders' deficit	-11,063,118	-503,069
Total liabilities, temporary equity and stockholders' deficit	$2,756,205	$814,571

CONSOLIDATED_BALANCE_SHEETS_Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical)(USD ($))	Dec. 31, 2013	Dec. 31, 2012
Temporary Equity	'	'
Convertible Preferred Stock, par value per share	$0.00	$0.00
Convertible Preferred Stock, shares authorized	10,000,000	10,000,000
Convertible Preferred Stock, shares issued	7,417	0
Convertible Preferred Stock, shares outstanding	7,417	0
Common Stock, par value per share	$0.00	$0.00
Common Stock, shares authorized	40,000,000	40,000,000
Common Stock, shares issued	5,301,693	5,460,600
Common Stock, shares outstanding	5,301,693	5,460,600

CONSOLIDATED_STATEMENTS_OF_OPE

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (USD $)	12 Months Ended			147 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2013
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS [Abstract]	'	'	'	'
Research and development expenses, net (Note 11)	$1,986,754	$1,920,690	$1,789,301	$12,463,158
General and administrative expenses (Note 12)	1,041,140	852,908	544,145	4,055,782
Other income	'	'	'	-912
Operating loss	3,027,894	2,773,598	2,333,446	16,518,028
Financing (income) expenses, net (Note 13)	6,768,959	-1,291	30,893	8,568,651
Loss for the period	9,796,853	2,772,307	2,364,339	25,086,679
Other comprehensive (income) loss:	'	'	'	'
Foreign currency translation adjustment	43,777	-13,709	39,052	52,702
Comprehensive loss for the period	$9,840,630	$2,758,598	$2,403,391	$25,139,381
Loss per share (Basic and Diluted) (Note 15)	$1.95	$0.52	$0.46	'

STATEMENTS_OF_CHANGES_IN_STOCK

STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (USD $)	Total	Common Stock [Member]	Additional paid in capital [Member]	Accumulated other comprehensive income (loss) [Member]	Receivable in respect of stock issuance [Member]	Deficit accumulated during development stage [Member]
Balance at Sep. 29, 2001	'	'	'	'	'	'
Balance, shares at Sep. 29, 2001	'	'	'	'	'	'
2,136,307 shares of Common Stock of par value $0.001 per share issued for cash	40,442	2,136	38,306	'	'	'
2,136,307 shares of Common Stock of par value $0.001 per share issued for cash, shares	'	2,136,307	'	'	'	'
Loss for the year	-63,293	'	'	'	'	-63,293
Other comprehensive income (loss)	-5	'	'	-5	'	'
Balance at Dec. 31, 2002	-22,856	2,136	38,306	-5	'	-63,293
Balance, shares at Dec. 31, 2002	'	2,136,307	'	'	'	'
Loss for the year	-350,290	'	'	'	'	-350,290
Other comprehensive income (loss)	-15,035	'	'	-15,035	'	'
Balance at Dec. 31, 2003	-388,181	2,136	38,306	-15,040	'	-413,583
Balance, shares at Dec. 31, 2003	'	2,136,307	'	'	'	'
Loss for the year	-288,233	'	'	'	'	-288,233
Other comprehensive income (loss)	-15,069	'	'	-15,069	'	'
Issuance of 42,727 shares of Common Stock for cash of $1.76 per share on March 16, 2004	75,000	43	74,957	'	'	'
Issuance of 42,727 shares of Common Stock for cash of $1.76 per share on March 16, 2004, shares	'	42,727	'	'	'	'
Issuance of 72,773 shares of Common Stock for cash of $ 1.72 per share on November 25, 2004	128,856	73	128,783	'	'	'
Issuance of 72,773 shares of Common Stock for cash of $ 1.72 per share on November 25, 2004, shares	'	72,773	'	'	'	'
Balance at Dec. 31, 2004	-487,627	2,252	242,046	-30,109	'	-701,816
Balance, shares at Dec. 31, 2004	'	2,251,807	'	'	'	'
Loss for the year	-1,055,594	'	'	'	'	-1,055,594
Other comprehensive income (loss)	8,542	'	'	8,542	'	'
Issuance of 218,281 shares of Common Stock for cash of $ 1.72 per share on January 14, 2005	375,000	218	374,782	'	'	'
Issuance of 218,281 shares of Common Stock for cash of $ 1.72 per share on January 14, 2005, shares	'	218,281	'	'	'	'
Issuance of 291,051 shares of Common Stock for cash of $ 1.72 per share on April 5, 2005	500,000	291	499,709	'	'	'
Issuance of 291,051 shares of Common Stock for cash of $ 1.72 per share on April 5, 2005, shares	'	291,051	'	'	'	'
Issuance of 59,389 shares of Common Stock for cash of $ 3.37 per share on May 31, 2005	200,000	60	199,940	'	'	'
Issuance of 59,389 shares of Common Stock for cash of $ 3.37 per share on May 31, 2005, shares	'	59,389	'	'	'	'
Stock-based compensation	189,616	52	189,564	'	'	'
Stock-based compensation, shares	'	52,147	'	'	'	'
Balance at Dec. 31, 2005	-270,063	2,873	1,506,041	-21,567	'	-1,757,410
Balance, shares at Dec. 31, 2005	'	2,872,675	'	'	'	'
Loss for the year	-1,282,842	'	'	'	'	-1,282,842
Other comprehensive income (loss)	-57,127	'	'	-57,127	'	'
Issuance of 87,315 shares of Common Stock for cash of $ 1.47 per share on January 26, 2006	128,205	87	128,118	'	'	'
Issuance of 87,315 shares of Common Stock for cash of $ 1.47 per share on January 26, 2006	'	87,315	'	'	'	'
Issuance of 1,899 shares of Common Stock for cash of $ 3.63 per share on March 31, 2006	6,890	2	6,888	'	'	'
Issuance of 1,899 shares of Common Stock for cash of $ 3.63 per share on March 31, 2006	'	1,899	'	'	'	'
Issuance of 13,786 shares of Common Stock for cash of $ 3.63 per share on June 16, 2006	50,000	14	49,986	'	'	'
Issuance of 13,786 shares of Common Stock for cash of $ 3.63 per share on June 16, 2006, shares	'	13,786	'	'	'	'
Issuance of 14,113 shares of Common Stock for cash of $ 3.63 per share on June 30, 2006	51,180	14	51,166	'	'	'
Issuance of 14,113 shares of Common Stock for cash of $ 3.63 per share on June 30, 2006, shares	'	14,113	'	'	'	'
Issuance of 51,207 shares of Common Stock for cash of $ 3.91 per share on August 15, 2006	200,000	51	199,949	'	'	'
Issuance of 51,207 shares of Common Stock for cash of $ 3.91 per share on August 15, 2006, shares	'	51,207	'	'	'	'
Issuance of 301,948 shares of Common Stock for cash of $ 4.31 per share on October 5, 2006	1,300,000	302	1,299,698	'	'	'
Issuance of 301,948 shares of Common Stock for cash of $ 4.31 per share on October 5, 2006, shares	'	301,948	'	'	'	'
Issuance of 348,402 shares of Common Stock for cash of $ 4.31 per share on December 14, 2006	1,372,495	349	1,372,146	'	'	'
Issuance of 348,402 shares of Common Stock for cash of $ 4.31 per share on December 14, 2006, shares	'	348,402	'	'	'	'
Stock-based compensation	277,497	63	277,434	'	'	'
Stock-based compensation, shares	'	63,395	'	'	'	'
Balance at Dec. 31, 2006	1,776,235	3,755	4,891,426	-78,694	'	-3,040,252
Balance, shares at Dec. 31, 2006	'	3,754,740	'	'	'	'
Loss for the year	-1,593,205	'	'	'	'	-1,593,205
Other comprehensive income (loss)	84,528	'	'	84,528	'	'
Stock-based compensation	274,659	29	274,630	'	'	'
Stock-based compensation, shares	'	28,707	'	'	'	'
Balance at Dec. 31, 2007	542,217	3,784	5,166,056	5,834	'	-4,633,457
Balance, shares at Dec. 31, 2007	'	3,783,447	'	'	'	'
Loss for the year	-1,528,981	'	'	'	'	-1,528,981
Other comprehensive income (loss)	110,134	'	'	110,134	'	'
Issuance of 61,989 shares of Common Stock for cash of $ 5.52 per share on September 27, 2008	342,000	62	341,938	'	'	'
Issuance of 61,989 shares of Common Stock for cash of $ 5.52 per share on September 27, 2008, shares	'	61,989	'	'	'	'
Issuance of 104,220 shares of Common Stock for cash of $ 5.52 per share on October 7, 2008	500,000	104	574,896	'	-75,000	'
Issuance of 104,220 shares of Common Stock for cash of $ 5.52 per share on October 7, 2008, shares	'	104,220	'	'	'	'
Stock-based compensation	84,380	'	84,380	'	'	'
Balance at Dec. 31, 2008	49,750	3,950	6,167,270	115,968	-75,000	-6,162,438
Balance, shares at Dec. 31, 2008	'	3,949,656	'	'	'	'
Loss for the year	-1,202,296	'	'	'	'	-1,202,296
Other comprehensive income (loss)	-13,367	'	'	-13,367	'	'
Issuance of 50,342 shares of Common Stock for cash of $6.02 per share in January 2009	303,000	50	302,950	'	'	'
Issuance of 50,342 shares of Common Stock for cash of $6.02 per share in January 2009, shares	'	50,342	'	'	'	'
Repayment of receivable in respect of stock issuance	75,000	'	'	'	75,000	'
Stock-based compensation	12,171	'	12,171	'	'	'
Balance at Dec. 31, 2009	-775,742	4,000	6,482,391	102,601	'	-7,364,734
Balance, shares at Dec. 31, 2009	'	3,999,998	'	'	'	'
Loss for the year	-2,788,446	'	'	'	'	-2,788,446
Other comprehensive income (loss)	-119,019	'	'	-119,019	'	'
Issuance of 530,600 shares of Common Stock for cash of $6.25 per share in December 2010, net of related expenses	2,357,032	531	2,356,501	'	'	'
Issuance of 530,600 shares of Common Stock for cash of $6.25 per share in December 2010, net of related expenses, shares	'	530,600	'	'	'	'
Stock-based interest compensation to convertible notes holders	1,214,943	194	1,214,749	'	'	'
Stock-based interest compensation to convertible notes holders, shares	'	194,391	'	'	'	'
Conversion of convertible notes	694,796	120	694,676	'	'	'
Conversion of convertible notes, shares	'	119,586	'	'	'	'
Stock-based compensation	14,575	'	14,575	'	'	'
Balance at Dec. 31, 2010	598,139	4,845	10,762,892	-16,418	'	-10,153,180
Balance, shares at Dec. 31, 2010	'	4,844,575	'	'	'	'
Loss for the year	-2,364,339	'	'	'	'	-2,364,339
Other comprehensive income (loss)	39,052	'	'	39,052	'	'
Issuance of 16,320 shares of Common Stock for cash of $ 6.25 per share on January 31, 2011, net of related expenses	83,180	16	83,164	'	'	'
Issuance of 16,320 shares of Common Stock for cash of $ 6.25 per share on January 31, 2011, net of related expenses, shares	'	16,320	'	'	'	'
Issuance of 90,768 shares of Common Stock for cash of $ 6.25 per share on March 31, 2011, net of related expenses	479,901	91	479,810	'	'	'
Issuance of 90,768 shares of Common Stock for cash of $ 6.25 per share on March 31, 2011, net of related expenses, shares	'	90,768	'	'	'	'
Issuance of 40,000 shares of Common Stock for cash of $ 6.25 per share on April 29, 2011, net of related expenses	191,722	40	191,682	'	'	'
Issuance of 40,000 shares of Common Stock for cash of $ 6.25 per share on April 29, 2011, net of related expenses, shares	'	40,000	'	'	'	'
Issuance of 34,200 shares of Common Stock for cash of $ 6.25 per share on May 31, 2011, net of related expenses	180,026	34	179,992	'	'	'
Issuance of 34,200 shares of Common Stock for cash of $ 6.25 per share on May 31, 2011, net of related expenses, shares	'	34,200	'	'	'	'
Issuance of 269,680 shares of Common Stock for cash of $ 6.25 per share on July 29, 2011, net of related expenses	1,466,385	270	1,466,115	'	'	'
Issuance of 269,680 shares of Common Stock for cash of $ 6.25 per share on July 29, 2011, net of related expenses, shares	'	269,680	'	'	'	'
Fair value of warrants with down-round protection issued in connection with Common Stock issuances	-83,899	'	-83,899	'	'	'
Stock-based compensation	378,072	'	378,072	'	'	'
Balance at Dec. 31, 2011	968,239	5,296	13,457,828	22,634	'	-12,517,519
Balance, shares at Dec. 31, 2011	'	5,295,543	'	'	'	'
Loss for the year	-2,772,307	'	'	'	'	-2,772,307
Other comprehensive income (loss)	-13,709	'	'	-13,709	'	'
Issuance of 165,057 shares of Common Stock for cash of $ 7.00 per share on November 19, 2012, net of related expenses	917,179	165	917,014	'	'	'
Issuance of 165,057 shares of Common Stock for cash of $ 7.00 per share on November 19, 2012, net of related expenses, shares	'	165,057	'	'	'	'
Warrants classified to equity due to the expiration of the down-round protection period/Warrants issued as consideration for placement services	48,007	'	48,007	'	'	'
Stock-based compensation	349,522	'	349,522	'	'	'
Balance at Dec. 31, 2012	-503,069	5,461	14,772,371	8,925	'	-15,289,826
Balance, shares at Dec. 31, 2012	5,460,600	5,460,600	'	'	'	'
Loss for the year	-9,796,853	'	'	'	'	-9,796,853
Other comprehensive income (loss)	43,777	'	'	43,777	'	'
Amount classified out of stockholders equity and presented as liability and temporary equity with respect to Common Stock replaced with units comprised of convertible Preferred Stock and warrants	-1,140,349	-163	-1,140,186	'	'	'
Amount classified out of stockholders equity and presented as liability and temporary equity with respect to Common Stock replaced with units comprised of convertible Preferred Stock and warrants, shares	'	-162,907	'	'	'	'
Conversion of Preferred Stock	23,200	4	23,196	'	'	'
Conversion of Preferred Stock, shares	'	4,000	'	'	'	'
Stock dividend to certain Common Stock holders	'	'	278,263	'	'	-278,263
Warrants classified to equity due to the expiration of the down-round protection period/Warrants issued as consideration for placement services	562,805	'	562,805	'	'	'
Dividend on convertible Preferred Stock	-288,248	'	'	'	'	-288,248
Stock-based compensation	35,619	'	35,619	'	'	'
Balance at Dec. 31, 2013	($11,063,118)	$5,302	$14,532,068	$52,702	'	($25,653,190)
Balance, shares at Dec. 31, 2013	5,301,693	5,301,693	'	'	'	'

STATEMENTS_OF_CHANGES_IN_STOCK1

STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical) (USD $)

0 Months Ended

1 Months Ended

15 Months Ended

Nov. 19, 2012

Jul. 29, 2011

31-May-11

Apr. 29, 2011

Mar. 31, 2011

Jan. 31, 2011

Dec. 30, 2010

Dec. 16, 2010

Oct. 07, 2008

Sep. 27, 2008

Dec. 14, 2006

Oct. 05, 2006

Aug. 15, 2006

Jun. 30, 2006

Jun. 16, 2006

Mar. 31, 2006

Jan. 26, 2006

31-May-05

Apr. 05, 2005

Jan. 14, 2005

Nov. 25, 2004

Mar. 16, 2004

Dec. 31, 2010

Jan. 31, 2009

Dec. 31, 2002

STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common stock issued, price per share

$7

$6.25

$6.25

$6.25

$6.25

$6.25

$6.25

$6.25

$5.52

$5.52

$4.31

$4.31

$3.91

$3.63

$3.63

$3.63

$1.47

$3.37

$1.72

$1.72

$1.72

$1.76

$6.25

$6.02

$0.00

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended			147 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2013
Cash flows from operating activities:	'	'	'	'
Loss for the period	($9,796,853)	($2,772,307)	($2,364,339)	($25,086,679)
Adjustments to reconcile loss for the period to net cash used in operating activities:	'	'	'	'
Depreciation	33,684	25,546	23,045	191,717
Increase (decrease) in liability for employee rights upon retirement	-9,959	-17,237	1,127	196,506
Stock-based compensation	35,619	349,522	378,072	1,616,044
Stock-based interest compensation to convertible notes holders	'	'	'	1,214,943
Issuance costs allocated to warrants with down-round protection	390,928	'	'	390,928
Change in the fair value of warrants issued with down-round protection	6,251,242	-35,892	'	6,215,350
Linkage difference on principal of loans from stockholders	14,382	9,849	24,934	201,280
Interest on convertible notes	'	'	'	78,192
Gain on sale of property and equipment	'	'	'	-912
Gain from trading marketable securities	'	'	'	-12,920
Changes in assets and liabilities:	'	'	'	'
Decrease (increase) in other current assets	-5,234	14,106	-23,968	-74,652
Increase (decrease) in accounts payable	-77,259	48,850	64,697	44,733
Increase (decrease) in other current liabilities	-54,317	80,574	-19,681	233,643
Net cash used in operating activities	-3,217,767	-2,296,989	-1,916,113	-14,791,827
Cash flows from investment activities:	'	'	'	'
Decrease (increase) in funds in respect of employee rights upon retirement	-40,029	-6,387	14,436	-149,221
Purchase of property and equipment	-64,252	-11,347	-54,619	-284,372
Proceeds from sale of property and equipment	'	'	'	4,791
Investment in marketable securities	'	'	'	-388,732
Proceeds from sale of marketable securities	'	'	'	406,995
Short-term loan granted to related party, net of repayments	'	'	'	-14,252
Net cash used in investment activities	-104,281	-17,734	-40,183	-424,791
Cash flows from financing activities	'	'	'	'
Credit from banking institutions (repayment)	-38,801	36,348	-18,669	-8,671
Proceeds from issuance of convertible notes	'	'	'	1,144,000
Repayment of convertible notes	'	'	'	-527,396
Proceeds from issuance of Common Stock, net of issuance expenses	'	917,179	2,401,214	11,323,559
Dividend to Preferred Stockholders	-288,248	'	'	-288,248
Proceeds allocated to convertible Preferred Stock, net of issuance expenses	3,960,958	'	'	3,960,958
Proceeds allocated to warrants with down-round protection, net of issuance expenses	1,421,983	'	'	1,421,983
Proceeds from stockholders loans	'	'	'	347,742
Net cash provided by financing activities	5,055,892	953,527	2,382,545	17,373,927
Effect of exchange rate changes on cash and cash equivalents	108,656	8,103	-23,993	228,602
Increase (decrease) in cash and cash equivalents	1,842,500	-1,353,093	402,256	2,385,911
Cash and cash equivalents at beginning of the period	543,411	1,896,504	1,494,248	'
Cash and cash equivalents at end of the period	$2,385,911	$543,411	$1,896,504	$2,385,911

CONSOLIDATED_STATEMENTS_OF_CAS1

CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) (USD $)	12 Months Ended
	Dec. 31, 2013
Conversion of Stock [Line Items]	'
Conversion of common equity to Units	$1,140,186
Stock dividend	278,263
Non-cash compensation expense	562,805
Issuance expenses, expensed as incurred	390,928
Costs recorded as a reduction of temporary equity	171,877
Conversion Allocated to Preferred Stock [Member]	'
Conversion of Stock [Line Items]	'
Amount allocated	839,469
Conversion Allocated to Warrants [Member]	'
Conversion of Stock [Line Items]	'
Amount allocated	$300,717

GENERAL

GENERAL	12 Months Ended
	Dec. 31, 2013
GENERAL [Abstract]	'
GENERAL	'
	NOTE 1	-	GENERAL
		A.	Integrity Applications, Inc. (the "Company") was incorporated on May 18, 2010 under the laws of the State of Delaware.  On July 15, 2010, Integrity Acquisition Corp. Ltd. (hereinafter: "Integrity Acquisition"), a wholly owned Israeli subsidiary of the Company, which was established on May 23, 2010, completed a merger with A.D. Integrity Applications Ltd. (hereinafter: "Integrity Israel"), an Israeli corporation that was previously held by the stockholders of the Company.  Pursuant to the merger, all equity holders of Integrity Israel received the same proportional ownership in the Company as they had in Integrity Israel prior to the merger. Following the merger, Integrity Israel remained a wholly-owned subsidiary of the Company.  As the merger transaction constituted a structural reorganization, the merger has been accounted for at historical cost in a manner similar to a pooling of interests.  On this basis, stockholders' equity has been retroactively restated such that each ordinary share of Integrity Israel is reflected in stockholders' equity as a share of Common Stock of the Company as of the date of the issuance thereof by Integrity Israel.  In addition, the historical financial statements of the Company for all dates prior to May 18, 2010 have been retroactively restated to reflect the activities of Integrity Israel.
		Integrity Israel was incorporated in 2001 and commenced its operations in 2002.  Integrity Israel, a medical device company, focuses on the design, development and commercialization of non-invasive glucose monitoring devices for home use by persons suffering with diabetes.
		Since its inception, Integrity Israel has devoted substantially all of its efforts to business planning, research and development and raising capital, and has not yet generated any revenues.  Accordingly, Integrity Israel (and therefore the Company) is considered to be in the development stage as defined in Financial Accounting Standards Board ("FASB") Accounting Standards Codification (ASC) Topic 915, "Development Stage Entities".
		B.	Going concern uncertainty
		Since its incorporation, the Company did not conduct any material operations other than those carried out by Integrity Israel.  The development and commercialization of Integrity Israel's product is expected to require substantial expenditures.  Integrity Israel and the Company (collectively, the "Group") have not yet generated any revenues from operations, and therefore they are dependent upon external sources for financing their operations. Since inception, Integrity Israel and the Company have incurred accumulated losses of $25,086,679, stockholder's deficit of $11,063,118 and cumulative negative operating cash flow of $ 14,791,827.  These factors raise substantial doubt about the Group's ability to continue as a going concern.  The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.  During 2011, the Company raised funds via the issuance of Common Stock in a total amount of approximately $2.4 million (net of related expenses).  During 2012, the Company raised a total amount of approximately $1.0 million (net of related expenses) from the issuance of Common Stock. During 2013, the Company raised funds in an approximate amount of $5.3 million (net of related expenses) from the Issuance of units (the "Units") consisting of shares of the Company's Series A Convertible Preferred Stock (the "Preferred Stock") and detachable warrants to purchase shares of the Company's Common Stock (See Note 10M). As more fully described in Note 10A2, the Company will not be permitted to, among other things, incur indebtedness without the written consent of the holders of a majority in stated value of the outstanding Preferred Stock. Until such time as the Group generates sufficient revenue to fund its operations (if ever), the Group plans to finance its operations through the sale of equity and/or debt securities and, to the extent available, short term and long term loans. There can be no assurance that Integrity Israel and the Company will succeed in obtaining the necessary financing to continue their operations.
		C.	Stock split
		The Board of Directors and stockholders of the Company approved in July 2010 a stock split of the outstanding shares of Common Stock and options to purchase shares of Common Stock of the Company, pursuant to which each share of Common Stock and each stock option was split into 2.1363 shares of Common Stock or options, as applicable (the "split").  The split became effective as of July 23, 2010. Unless otherwise noted, all share and option amounts for all periods presented have been retroactively restated to give effect to the split.
		D.	Risk factors
		The Group has limited operating history and face a number of risks, including uncertainties regarding finalization of the development process, demand and market acceptance of the Group's products, the effects of technological changes, competition and the development of products by competitors.  Additionally, other risk factors also exist, such as the ability to manage growth and the effect of planned expansion of operations on the Group's future results. In addition, the Group expects to continue incurring significant operating costs and losses in connection with the development of its products and marketing efforts. The Group has not yet generated any revenues from its operations to fund its activities and therefore the Group is dependent on the receipt of additional funding from its stockholders and investors in order to continue as a going concern (See Note 1B).
		E.	On May 14, 2013, the Securities and Exchange Commission declared effective a Registration Statement on Form S-1 registering for resale by the holders thereof an aggregate of 2,824,471 shares of the Company's Common Stock, consisting of 1,284,925 Shares issuable to certain of the selling stockholders named in the Registration Statement (the "Selling Stockholders") upon conversion of outstanding shares of the Company's Preferred Stock, 1,539,546 Shares issuable to certain of the Selling Stockholders upon exercise of outstanding warrants and 2,150 shares of Common Stock previously issued to a Selling Stockholder.

SUMMARY_OF_SIGNIFICANT_ACCOUNT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2013
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]	'
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	'
	NOTE 2	-	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
		The consolidated financial statements were prepared in accordance with accounting principles generally accepted in the United States of America (US GAAP).
		A.	Use of estimates in the preparation of financial statements
		The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the consolidated financial statements, and the reported amounts of expenses during the reporting periods. Actual results could differ from those estimates. As applicable to these consolidated financial statements, the most significant estimates and assumptions relate to (a) the allocation of the proceeds and the related issuance costs of Units consisting of convertible Preferred Stock and warrants with down round protection, (b) the fair value estimate of the warrants with the down-round protection and (c) the going concern assumptions.
		B.	Functional currency
		The functional currency of the Company is the US dollar, which is the currency of the primary economic environment in which it operates.  In accordance with ASC 830, "Foreign Currency Matters" (ASC 830), balances denominated in or linked to foreign currency are stated on the basis of the exchange rates prevailing at the applicable balance sheet date.  For foreign currency transactions included in the statement of operations, the exchange rates applicable on the relevant transaction dates are used.  Gains or losses arising from changes in the exchange rates used in the translation of such transactions are carried as financing income or expenses. The functional currency of Integrity Israel is the New Israeli Shekel ("NIS") and its financial statements are included in consolidation, based on translation into US dollars.  Accordingly, assets and liabilities were translated from NIS to US dollars using year-end exchange rates, and income and expense items were translated at average exchange rates during the year. Gains or losses resulting from translation adjustments are reflected in stockholders' equity (deficit), under "accumulated other comprehensive income (loss)".
			Year ended December 31,
			2013		2012		2011
	Official exchange rate of NIS 1 to US dollar			0.288		0.268		0.262
		C.	Principles of consolidation
		The consolidated financial statements include the accounts of the Company and its subsidiary. All intercompany balances and transactions have been eliminated in consolidation.
		As described in Note 1A above, the merger of Integrity Israel has been accounted for in a manner similar to a pooling of interests at historical cost.
		D.	Cash and cash equivalents
		The Group considers all short-term investments, which are highly liquid investments with original maturities of three months or less at the date of purchase, to be cash equivalents.
		E.	Property and equipment, net
		1	Property and equipment are stated at cost, net of accumulated depreciation.  Depreciation is calculated using the straight-line method over the estimated useful lives of the assets.  When an asset is retired or otherwise disposed of, the related carrying value and accumulated depreciation are removed from the respective accounts and the net difference less any amount realized from disposition is reflected in the statements of operations.
		2	Rates of depreciation:
		%
	Computers	33
	Furniture and office equipment	15-Jul
	Leasehold improvements	Shorter of lease term
		and 10 years
		F.	Impairment of long-lived assets
		The Group's long-lived assets are reviewed for impairment in accordance with ASC 360, "Property, Plant and Equipment", whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.  Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the asset.  If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds its fair value.  To date the Group did not incur any material impairment losses.
		G.	Deferred income taxes
		The Group accounts for income taxes in accordance with ASC 740, "Income Taxes". Accordingly, deferred income taxes are determined utilizing the asset and liability method based on the estimated future tax effects of differences between the financial accounting and the tax bases of assets and liabilities under the applicable tax law.  Deferred tax balances are computed using the enacted tax rates expected to be in effect when these differences reverse.  Valuation allowances in respect of deferred tax assets are provided for, if necessary, to reduce deferred tax assets to amounts more likely than not to be realized.
		The Group accounts for uncertain tax positions in accordance with ASC Topic 740-10, which prescribes detailed guidance for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in an enterprise's financial statements. According to ASC Topic 740-10, tax positions must meet a more-likely-than-not recognition threshold. The Group's accounting policy is to classify interest and penalties relating to uncertain tax positions under income taxes, however the Group did not recognize such items in its fiscal 2013, 2012 and 2011 financial statements and did not recognize any liability with respect to unrecognized tax position in its balance sheet.
		H.	Liability for employee rights upon retirement
		Integrity Israel's liability for employee rights upon retirement with respect to its Israeli employees is calculated pursuant to the Israeli Severance Pay Law, based on the most recent salary of each employee multiplied by the number of years of employment as of the balance sheet date. Employees are entitled to one month's salary for each year of employment, or ratable portion thereof for periods less than one year. Integrity Israel makes monthly deposits to insurance policies and severance pay funds.
		The deposited funds may be withdrawn upon the fulfillment of Integrity Israel's severance obligations pursuant to Israeli severance pay laws or labor agreements with its employees.  The value of the deposited funds is based on the cash surrender value of these policies, and includes immaterial profits or losses.
		Commencing 2011, Integrity Israel's agreements with its Israeli employees are in accordance with Section 14 of the Severance Pay Law. Payments in accordance with Section 14 release the employer from any future severance payments in respect of those employees. Related obligations and liabilities under Section 14 are not recorded as an asset or as a liability in the Company's balance sheet.
		Severance expenses for the year ended December 31, 2013, 2012 and 2011 amounted to $91,588, $78,556 and $42,358, respectively.
		I.	Research and development expenses
			Research and development expenses are charged to operations as incurred.  Grants received by Integrity Israel from the Government of Israel through the Office of the Chief Scientist of the Ministry of Industry, Trade and Labor (the "OCS") for development of approved projects were recognized as a reduction of expenses when the related costs were incurred.
		J.	Royalty-bearing grants
		Royalty-bearing grants from the OCS for funding approved research and development projects are recognized at the time Integrity Israel is entitled to such grants, on the basis of the costs incurred and reduce research and development costs.  The cumulative research and development grants received by Integrity Israel from inception through December 2004 amounted to $93,462.  Integrity Israel has not received any research and development grants since December 2004.
		As of December 31, 2013, 2012 and 2011, the Group did not accrue or pay any royalties to the OCS.
		K.	Loss per share
		Basic loss per share is computed by dividing loss for the period by the weighted average number of shares of Common Stock outstanding during the period. Securities that may participate in dividends with the Common Stock (such as the convertible Preferred Stock) are included in the computation of basic earnings per share using the two class method. However, in periods of net loss, such participating securities are not included since the holders of such securities do not have a contractual obligation to share the losses of the Company.
		In computing diluted earnings per share, basic earnings per share are adjusted to reflect the potential dilution that could occur upon the exercise of options or warrants issued or granted using the "treasury stock method" and upon the conversion of Preferred Stock using the "if-converted method", if their effect is dilutive.
		L.	Stock-based compensation
		The Group measures and recognizes the compensation expense for all equity-based payments to employees based on their estimated fair values in accordance with ASC 718, "Compensation-Stock Compensation". Share-based payments including grants of stock options and shares are recognized in the statement of operations as an operating expense, based on the fair value of the award at the date of grant.  The fair value of options is estimated using the Black-Scholes option-pricing model and the fair value of share grants is estimated using recent transaction prices.  The Group has expensed compensation costs, net of estimated forfeitures, applying the accelerated vesting method, over the requisite service period or over the implicit service period when a performance condition affects the vesting, and it is considered probable that the performance condition will be achieved.
		Share-based payments awarded to consultants (non-employees) are accounted for in accordance with ASC Topic 505-50, "Equity-Based Payments to Non-Employees".
		M.	Fair value of financial instruments
		ASC Topic 825-10, "Financial Instruments" defines financial instruments and requires disclosure of the fair value of financial instruments held by the Group. The Group considers the carrying amount of cash and cash equivalents, other current assets, credit from banking institutions, accounts payable and other current liabilities balances, to approximate their fair values because of the short period of time between the origination of such instruments and their expected realization.  The warrants with down-round protection represent a derivative liability and therefore are measured and presented on the balance sheet at fair value. The fair value measurement of the warrants is classified as level 3. The Group did not estimate the fair value of the long-term loans from stockholders since their repayment schedule has not yet been determined.
		N.	Convertible notes
		The Group considered the provisions of ASC Topic 815, "Derivatives and Hedging", and determined that the conversion feature should not be separated from the host instrument.  Furthermore, the Group applied ASC Topic 470-20, "Debt - Debt with Conversion and Other Options" which clarifies the accounting for instruments with beneficial conversion features or contingency adjustable conversion ratios.  The Group has determined that the convertible notes did not include a beneficial conversion feature. The entire balance of the convertible notes (which were issued during fiscal year 2010) was either repaid in cash or converted into Common Stock during fiscal year 2010 (see also Note 10C).
		O.	Concentrations of credit risk
		Financial instruments that potentially subject the Group to concentrations of credit risk consist primarily of cash and cash equivalents.  Cash and cash equivalents are deposited with major banks in Israel and the United States of America. Management believes that such financial institutions are financially sound and, accordingly, minimal credit risk exists with respect to these financial instruments. The Group does not have any significant off-balance-sheet concentration of credit risk, such as foreign exchange contracts, option contracts or other foreign hedging arrangements.
		P.	Contingencies
		The Group records accruals for loss contingencies arising from claims, litigation and other sources when it is probable that a liability has been incurred and the amount can be reasonably estimated. These accruals are adjusted periodically as assessments change or additional information becomes available. Legal costs incurred in connection with loss contingencies are expensed as incurred.
		Q.	Temporary equity
		As more fully described in Note 10M, in March 2013 the Company issued convertible Preferred Stock which provide a liquidation preference and certain redemption rights for the benefit of the holders of such Preferred Stock upon the occurrence of certain events, some of which are not within the Company's control.  Accordingly, the convertible Preferred Stock is presented as temporary equity.
		Upon initial recognition, the Preferred Stock was measured based on the "residual approach". Accordingly, the amount allocated to the Preferred Stock was based on the gross proceeds (including the gross proceeds to the Company from the issuance of Common Stock that was subsequently replaced with Units - See Note 10L), net of the fair value of the detachable warrants and net of the direct issuance expenses that were allocated to the Preferred Stock.
		Since at the commitment date, the exercise price of the conversion feature (based on the effective conversion rate of the Preferred Stock into Common Stock) was higher than the estimated fair value of the Company's Common Stock, it was determined that the conversion feature was not beneficial.
		On each balance sheet date, the Company's management assesses the probability of redemption of the Preferred Stock. In the event that management determines such redemption to be probable as of an applicable balance sheet date, the Company will recognize a liability in an amount equal to the aggregate redemption price of the Preferred Stock. In addition, upon such determination, the difference between the amount that was allocated to the Preferred Stock (after deduction of issuance expenses) and such redemption amount will be accreted over the period beginning on the date that it becomes probable that the instrument will become redeemable and ending on the earliest redemption date.
		R.	Warrants with "down-round" protection
		The Company considered the provisions of ASC 815-40, "Derivatives and Hedging: Contracts in Entity's Own Equity", with respect to the detachable warrants that were issued to the Unit Purchasers, as described in Note 10M, and determined that as a result of the "down-round" protection that would adjust the exercise price of the warrants to the price at which the Company subsequently issues shares or other equity-linked financial instruments, if that price is less than the original exercise price of the warrants, such warrants cannot be considered as indexed to the Company's own stock. Accordingly, the warrants were recognized as derivative liability at their fair value on initial recognition. In subsequent periods, the warrants are marked to market with the changes in fair value recognized as financing expense or income in the consolidated statement of operations. The direct issuance expenses that were allocated to the detachable warrants were expensed as incurred.
		S.	Recently issued accounting pronouncements
		1	ASC Topic 220, "Comprehensive Income"
		Effective January 1, 2013, the Group adopted Accounting Standard Update No. 2013-02 "Comprehensive Income (Topic 220) - Reporting of Amounts Reclassified out of Accumulated Other Comprehensive Income" (ASU 2013-02). ASU 2013-02 requires an entity to provide information about amounts reclassified out of accumulated other comprehensive income.
		According to ASU 2013-02, significant items that are required under U.S. GAAP to be reclassified to net income in their entirety shall be presented by the respective line items of net income either on the face of the financial statements or in the footnotes. Items that are not required under U.S. GAAP to be reclassified to net income in their entirety are required to be cross-referenced to other disclosures required under U.S. GAAP that provide additional detail about those amounts. The adoption of ASU 2013-02 did not have a material impact on the financial position or results of operations of the Group.
		2	ASC Topic 210, "Balance Sheet"
	Effective January 1, 2013, the Group adopted Accounting Standard Update (ASU) 2011-11, "Balance Sheet (Topic 210) - Disclosures about Offsetting Assets and Liabilities" (ASU 2011-11). ASU 2011-11 enhances disclosures about financial instruments and derivative instruments that are either offset in accordance with the Accounting Standards Codification or are subject to an enforceable master netting arrangement or similar agreement.
	The amended guidance became effective, in a retrospective manner to all comparative periods presented, for annual reporting periods beginning on or after January 1, 2013, and interim periods within those annual periods.
	The adoption of ASU 2011-11 did not have a material impact on the financial position or results of operations of the Group.
	3	ASC Topic 830, Foreign "Currency Matters"
	In March 2013, the FASB issued Accounting Standards Update 2013-5, Foreign Currency Matters (Topic 830): Parent's Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity ("ASU 2013-5").
	ASU 2013-5 clarifies among other things that, when a reporting entity (parent) ceases to have a controlling financial interest in a subsidiary or group of assets that is a business (other than a sale of in-substance real estate or conveyance of oil and gas mineral rights) within a foreign entity, the parent is required to apply the guidance in Subtopic 830-30 to release any related cumulative translation adjustment into net income. Accordingly, the cumulative translation adjustment should be released into net income only if the sale or transfer results in the complete or substantially complete liquidation of the foreign entity in which the subsidiary or group of assets had resided.
	For public companies, the amendments in this Update will be effective prospectively for fiscal years (and interim reporting periods within those years) beginning after December 15, 2013. The amendments should be applied prospectively to derecognition events occurring after the effective date. Prior periods should not be adjusted. Early adoption is permitted. If an entity elects to early adopt the amendments, it should apply them as of the beginning of the entity's fiscal year of adoption. The adoption of the standard is not expected to have a material impact on the Group's consolidated results of operations and financial condition.

OTHER_CURRENT_ASSETS

OTHER CURRENT ASSETS	12 Months Ended
	Dec. 31, 2013
OTHER CURRENT ASSETS [Abstract]	'
OTHER CURRENT ASSETS	'
	NOTE 3	-	OTHER CURRENT ASSETS
			US dollars
			December 31,
			2013		2012
	Prepaid expenses			29,044		29,460
	Government Institution (*)			64,008		52,012
				93,052		81,472
		(*)	Represents amounts advanced by Integrity Israel to the Israeli tax authorities or amounts owed to Integrity Israel by the Israeli Value Added Tax authorities.

PROPERTY_AND_EQUIPMENT_NET

PROPERTY AND EQUIPMENT, NET	12 Months Ended
	Dec. 31, 2013
PROPERTY AND EQUIPMENT, NET [Abstract]	'
PROPERTY AND EQUIPMENT, NET	'
	NOTE 4	-	PROPERTY AND EQUIPMENT, NET
			US dollars
			December 31,
			2013			2012
	Computers			110,930			85,517
	Furniture and office equipment			168,957			114,982
	Leasehold improvements			25,761			23,953
				305,648			224,452
	Less - accumulated depreciation			(198,439	)		(154,252	)
				107,209			70,200
		During the years ended December 31, 2013, 2012 and 2011, depreciation expenses amounted to $33,684, $25,546 and $23,045, respectively, and new equipment purchases amounted to $64,252, $11,347 and $54,619, respectively.

ACCOUNTS_PAYABLE

ACCOUNTS PAYABLE	12 Months Ended
	Dec. 31, 2013
ACCOUNTS PAYABLE [Abstract]	'
ACCOUNTS PAYABLE	'
	NOTE 5	-	ACCOUNTS PAYABLE
			US dollars
			December 31,
			2013		2012
	Open accounts			8,085		96,870
	Checks payable			41,702		25,667
				49,787		122,537

OTHER_CURRENT_LIABILITIES

OTHER CURRENT LIABILITIES	12 Months Ended
	Dec. 31, 2013
OTHER CURRENT LIABILITIES [Abstract]	'
OTHER CURRENT LIABILITIES	'
	NOTE 6	-	OTHER CURRENT LIABILITIES
			US dollars
			December 31,
			2013		2012
	Employees and related institutions			217,027		184,394
	Accrued expenses and other			44,093		113,595
				261,120		297,989

LINE_OF_CREDIT

LINE OF CREDIT	12 Months Ended
	Dec. 31, 2013
LINE OF CREDIT [Abstract]	'
LINE OF CREDIT	'
	NOTE 7	-	LINE OF CREDIT
		As of December 31, 2013, the Group has an unutilized credit line of approximately $86,430 (NIS 300,000) with its Israeli banks. Borrowings under the line of credit are secured by our funds on deposit with the bank at the time of borrowing, which generally must be sufficient to cover the principal amount of the borrowings in full.

LONGTERM_LOANS_FROM_STOCKHOLDE

LONG-TERM LOANS FROM STOCKHOLDERS	12 Months Ended
	Dec. 31, 2013
LONG-TERM LOANS FROM STOCKHOLDERS [Abstract]	'
LONG-TERM LOANS FROM STOCKHOLDERS	'
	NOTE 8	-	LONG-TERM LOANS FROM STOCKHOLDERS
		During the years 2003-2004, Integrity Israel received loans from stockholders (three separate lenders).  The loans are indexed to the Israeli Consumer Price Index from their origination date and bear no interest.
		The Group will be required to pay the loan, in quarterly installments, commencing on the first quarter following the first fiscal year in which the Group reports net profit in its annual report.  At such time, the Group will be required to make quarterly payments equal to 10% of its total sales for each quarter until the loans have been repaid in full.  Notwithstanding the repayment mechanism, the Group will not be required to repay the loans during any period in which such payment would cause a deficit in the Group's working capital. Since its inception, the Group has not reported any profits and accordingly, the loans have been presented as long-term liabilities.
		As of December 31, 2013, no repayments of the stockholders loans have been made.

COMMITMENTS_AND_CONTINGENT_LIA

COMMITMENTS AND CONTINGENT LIABILITIES	12 Months Ended
	Dec. 31, 2013
COMMITMENTS AND CONTINGENT LIABILITIES[Abstract]	'
COMMITMENTS AND CONTINGENT LIABILITIES	'
	NOTE 9	-	COMMITMENTS AND CONTINGENT LIABILITIES
		A.	On March 4, 2004, the OCS provided Integrity Israel with a grant of approximately $93,462 (NIS 420,000), for its plan to develop a non-invasive blood glucose monitor (the "Development Plan"). Integrity Israel is required to pay royalties to the OCS at a rate ranging between 3-5% of the proceeds from the sale of the Group's products arising from the Development Plan up to an amount equal to $93,462, plus interest at LIBOR from the date of grant. As of December 31, 2013, the contingent liability with respect to royalty payment on future sales equals approximately $93,462, excluding interest. Such contingent obligation has no expiration date.
		B.	Integrity Israel currently leases approximately 3,100 sq. ft. of office space in the city of Ashkelon, Israel for its principal offices and prototype laboratory.  The lease term began on February 1, 2006 and was extended until January 31, 2009.  Pursuant to a verbal agreement with the landlord, Integrity Israel currently leases this facility on a monthly basis at a cost of approximately $3,300 (NIS 11,500).
		C.	In 2010, the Company engaged Andrew Garrett, Inc. as its exclusive placement agent (the "Placement Agent") in connection with an offering on a "best efforts" basis of a minimum 560,000 shares and a maximum of 2,000,000 shares of the Company's Common Stock at a price of $6.25 per share (the "2010 Offering").  Pursuant to a placement agent agreement with the Placement Agent, the Placement Agent (or its sub-agents) was entitled to receive, as a commission, an amount equal to 7% of the funds raised in the offerings, such amounts to be paid in cash, plus 3% of the funds as a management fee plus a 3% non-accountable expense allowance (13% in the aggregate).  In addition, the placement agent agreement required the Company to issue to the Placement Agent (or its sub-agents) warrants to purchase up to 10% of the shares of Common Stock issued to investors (or underlying convertible securities issued to investors) in connection with the offerings at a price per share that will be equal to the offering price and subject to certain price adjustments.  In 2012, the Company engaged the Placement Agent, on substantially the same financial terms as those described above, in connection with an offering of up to $5,000,000 of its Common Stock, which offering was subsequently converted to an offering of up to $7,500,000 of Units consisting of Preferred Stock and Warrants (the "2012 Offering").
		In connection with the 2010 Offering and the 2012 Offering, the Company paid to the Placement Agent $820,493, $150,202 and $366,412, in cash during 2013, 2012 and 2011, respectively.  See Note 10C-10N as per warrants issued to the Placement Agent.
		D.	Y.H. Dimri Holdings, which was a shareholder of Integrity Israel prior to the reorganization and merger described in Note 1 ("Dimri"), has alleged (post the reorganization) that, in connection with such reorganization, certain of Dimri's rights in Integrity Israel were violated.  Under Dimri's investment agreement, certain rights in Integrity Israel were granted to Dimri, including an anti-dilution provision that provided that Dimri's holdings in Integrity Israel would not be diluted below 18% of Integrity Israel's issued capital shares as a result of any investment in Integrity Israel.  On the date of the reorganization, Dimri owned 18% of Integrity Israel's ordinary shares and, therefore, upon the completion of the reorganization, Dimri was entitled to receive 18% of the shares of Common Stock of the Company outstanding on such date in exchange for his shares in Integrity Israel, subject to the fulfillment of certain requirements.  The Company's management, considering the legal advice of its Israeli legal counsel, believes that, given that Dimri no longer owns shares in Integrity Israel as a result of the reorganization, rights attached to the shares in Integrity Israel no longer exist in Integrity Israel and do not and have never existed in the Company.  However, Dimri has refused to acknowledge or agree to the termination of these rights and has challenged the Company's position.
		On June 23, 2011, Dimri appealed to the District Court of HaMerkaz District in Petah Tikva, Israel, requesting the court to appoint an arbitrator to decide the dispute between Integrity Israel, the founders of Integrity Israel and Mr. Dimri (HPB 40754-06-11). On September 25, 2011, Integrity Israel's legal counsel filed an answer with the Court, disputing the facts and allegation raised in Dimri's motion and suggesting choosing an arbitrator with certain capacities, experience and skills. On December 26, 2011, an arbitrator was appointed in this matter.
		On March 20, 2012, Dimri submitted a statement of claim to the arbitrator and pled for a declaratory judgment against Integrity Israel and the founders of Integrity Israel.  Dimri claimed that its rights under the loan and investment agreement, Integrity Israel's Articles of Association and two other internal agreements entered into among the founders of Integrity Israel are valid and in effect.  Dimri also pled for an injunction requiring the founders of Integrity Israel to transfer shares of the Company's Common Stock held by them to Dimri, from time to time, in such amounts necessary so that Dimri's holdings in the Company would not be diluted below 18% of the Company's issued share capital at any time.  The defendants in the arbitration submitted a statement of defense on May 28, 2012 and Dimri submitted a reply on June 14, 2012.  At a preliminary session held on June 19, 2012, the arbitrator suggested that the parties meet with him in order to examine whether a settlement can be reached.  A meeting for this purpose had been set for August 27, 2012 but has been postponed by the arbitrator.  After several postponements, Dimri submitted its affidavits on October 16, 2012. The defendants submitted their affidavits on February 7, 2013. Testimony and summary hearings have been conducted during June 2013. Thereafter, the parties have entered into settlement discussions, which have not yet been concluded.
		The Company does not know what other actions Dimri will ultimately bring, if any, and against whom they will be brought. Nevertheless, the Company, its legal counsel and Integrity Israel's legal counsel believe that the Company and Integrity Israel have substantial defenses to any such claims and appropriate claims and counterclaims of their own and they intend to strongly defend against any such action by Dimri and to assert their own claims and counterclaims as they deem necessary.
		Notwithstanding the aforesaid, the Company, considering the advice of its Israeli legal counsel, is unable to assess or make any estimate of the amount of the reasonably possible range of loss, if any. Accordingly, no provision has been made for this claim.

WARRANT_WITH_DOWNROUND_PROTECT

WARRANT WITH DOWN-ROUND PROTECTION, TEMPORARY EQUITY AND SHARE CAPITAL

12 Months Ended

Dec. 31, 2013

WARRANT WITH DOWN-ROUND PROTECTION, TEMPORARY EQUITY AND SHARE CAPITAL [Abstract]

'

WARRANT WITH DOWN-ROUND PROTECTION, TEMPORARY EQUITY AND SHARE CAPITAL

'

NOTE 10

-

WARRANT WITH DOWN-ROUND PROTECTION, TEMPORARY EQUITY AND SHARE CAPITAL

A.

1

Description of the rights attached to the Common Stock

Each share of Common Stock entitles the holder to one vote, either in person or by proxy, on each matter submitted to the approval of the Company's stockholders.  The holders of Common Stock are not permitted to vote their shares cumulatively.  As described below, holders of Preferred Stock are entitled to vote together with the holders of Common Stock on an as-converted basis.  Accordingly, the holders of the Company's Common Stock together with the holders of the Preferred Stock who hold, in the aggregate, more than fifty percent of the total voting rights can elect all of the directors and, in such event, the holders of the remaining shares will not be able to elect any of such directors.  The vote of the holders of a majority of the issued and outstanding shares of Common Stock, voting together with the holders of the Preferred Stock on an as converted basis, are entitled to vote thereon is sufficient to authorize, affirm, ratify or consent to any act or action submitted to the vote of the Company's stockholders, except as otherwise provided by law.

2

Description of the rights attached to the Preferred Stock

Holders of Preferred Stock are entitled to receive cumulative dividends at a rate of 5% per annum, based on the stated value per share of Preferred Stock, which was initially $1,000 per share.  Dividends on the Preferred Stock are payable quarterly on March 31, June 30, September 30 and December 31 of each year, beginning on March 31, 2013, and on each conversion date (with respect to the shares of Preferred Stock being converted).  Until September 13, 2013, dividends were payable only in cash. Thereafter, dividends on the Preferred Stock are payable, at the option of the Company, in cash and/or, if certain conditions are satisfied (including, among others, that the volume weighted average trading price for the Common Stock on its principal trading market is equal to or greater than 110% of the then current conversion price for the Preferred Stock for five consecutive trading days prior to the dividend payment date), in shares of Common Stock, valued at the then current conversion price of the Preferred Stock.  The Company will incur a late fee of 9% per annum, payable in cash, on dividends that are not paid within three trading days of the applicable dividend payment date. During the year ended December 31, 2013 the Company paid an aggregate of $288,248 in cash as dividend to its Preferred Stockholders.

The Company may become obligated to redeem the Preferred Stock in cash upon the occurrence of certain triggering events, including, among others, a material breach by the Company of certain contractual obligations to the holders of the Preferred Stock, the occurrence of a change in control of the Company, the occurrence of certain insolvency events relating to the Company, or the failure of the Common Stock to continue to be listed or quoted for trading on one or more specified United States securities exchanges or a regulated quotation service.  In addition, upon the occurrence of certain triggering events, each holder of Preferred Stock will have the option to require the Company to redeem such holder's shares of Preferred Stock for a redemption price payable in shares of Common Stock or receive an increased dividend rate of 9% on all of such holder's outstanding Preferred Stock.

Subject to certain conditions, the Company will have the option to force the conversion of the Preferred Stock (in whole or in part) if the volume weighted average price for the Common Stock on its principal trading market exceeds $11.60 for each of any 20 trading days during any 30 consecutive Trading Day period and the average daily dollar trading value for the Common Stock during such 30 day period exceeds $100,000.

If the Company fails to timely deliver certificates for shares of Common Stock issuable upon conversion of the Preferred Stock (the "Conversion Shares") and, as a result, the holder is required by its brokerage firm to purchase shares of Common Stock to deliver in satisfaction of a sale by such holder of the Conversion Shares (a "Buy-In"), the Company will be required to: (a) pay the converting holder in cash an amount equal to the amount, if any, by which such holder's total purchase price (including any brokerage commissions) for the shares of Common Stock so purchased exceeds the product of (i) the aggregate number of Conversion Shares due to the holder, multiplied by (ii) the actual sale price at which the sell order giving rise to such purchase obligation was executed (including any brokerage commissions); and (b) at the option of such holder, either reissue (if surrendered) the shares of Preferred Stock equal to the number of shares of Preferred Stock submitted for conversion (in which case, such conversion will be deemed rescinded) or deliver to such holder the number of shares of Common Stock that would have been issued if the Company had timely complied with its delivery requirements.

In addition, the Company will be required to pay partial liquidated damages of $10 for each $1,000 of stated value of any shares of Preferred Stock which have been converted by a holder and in respect of which the Company fails to deliver Conversion Shares by the eighth trading day following the applicable conversion date.

As long as at least 15% of the originally issued shares of Preferred Stock are outstanding, without the written consent of the holders of a majority in stated value of the outstanding Preferred Stock, the Company will not be permitted to, among other things, incur indebtedness or liens not permitted under the Certificate of Designations; repay, repurchase, pay dividends on or otherwise make distributions in respect of any shares of Common Stock or other securities junior to the Preferred Stock; or enter into certain transactions with affiliates of the Company.

Subject to the beneficial ownership limitation described below, holders of Preferred Stock will vote together with the holders of Common Stock on an as-converted basis.  Holders will not be permitted to convert their Preferred Stock if such conversion would cause such holder to beneficially own more than 4.99% of the outstanding number of shares of Common Stock outstanding after giving effect to such conversion (subject to increase to 9.99%, at the option of the holder, upon no less than 61 days prior written notice to the Company) (the "Beneficial Ownership Limitation").  In addition, no holder may vote any shares of Preferred Stock (on an as converted to Common Stock basis) in excess of the Beneficial Ownership Limitation.

Subject to certain limitations, so long as any Purchaser holds any shares of Preferred Stock, if (1) the Company sells any shares of Common Stock or other securities convertible into, or rights to acquire, Common Stock and (2) a Purchaser then holding Preferred Stock, Warrants, Conversion Shares or Warrant Shares (defined below) reasonably believes that any of the terms and conditions appurtenant to such issuance or sale are more favorable to the purchaser in such subsequent sale of securities than are the terms and conditions granted to such Purchaser, then the Purchaser will be permitted to require the Company to amend the terms of this transaction (only with respect to such Purchaser) so as to match the terms of the subsequent issuance (including, for the avoidance of doubt, any terms and provisions that are or may be less favorable to such Purchaser).

The conversion price of the shares of Preferred Stock that were included in the Units is subject to adjustment for certain issuances of Common Stock or other securities of the Company at an effective price per share that is lower than the conversion price then in effect ($5.80 per share at December 31, 2013), as well as for stock splits, stock dividends, combinations of shares, similar recapitalization transactions and certain pro-rata distributions to common stockholders.

B.

Stock-based compensation

1

Grants to non-employees

a.

During 2005, Integrity Israel granted to three consultants an aggregate sum of 144,250 of its ordinary shares of NIS 0.01 par value as consideration for consulting services.  The compensation expense was recorded as an expense over the consulting service period (varying from 2 months to 2 years).

The non-cash compensation recorded with respect to such grants was $123,625, $229,564 and $175,516 for the years 2007, 2006 and 2005, respectively.  The fair value of the shares was based on the recent share price applicable.

Following the merger with Integrity Israel, the shares were replaced with shares of Common Stock of the Company.

b.

In October 2006, Integrity Israel granted 45,531 options with an exercise price of $4.305 per share in consideration of investor finders, of which 17,657 were forfeited.

In November 2008, Integrity Israel granted 8,989 options with an exercise price of $5.517 per share in consideration of investor finders, of which 5,365 were forfeited.

The fair value of each such grant was based on the most recent share price with respect to the relevant grant date.

Following the merger with Integrity Israel, the options were replaced with options of the Company.

c.

In connection with the 2010 Offering, the Company issued to the Placement Agent warrants to purchase 45,097 and 84,459 shares, respectively, of the Company's Common Stock, with an exercise price of $6.25 per share, in 2011 and 2010, respectively.  The warrants expire on the fifth anniversary of the date on which the shares of Common Stock underlying such warrants are fully registered with the SEC.  The warrants include customary adjustment provisions for stock splits, reorganizations and other similar transactions and in addition, the warrants that were issued to the placement agent, included a limited Period (until September 1, 2012) Down-Round Protection under which the strike price of the warrants would be adjusted to a price per share at which the Company will subsequently issue stock, if such price per share is less than the original strike price of the warrants.

In connection with the 2012 Offering, the Company issued to the Placement Agent warrants to purchase up to 256,554 shares of Common Stock.  Half of such warrants are exercisable at an exercise price of $5.80 per share, and the remainders of such warrants are exercisable at any exercise price of $6.96 per share.  Such warrants have substantially the same terms as those issued to the Unit Purchasers (see Note 10M below).  In addition, on May 13, 2013, the Company issued to the Placement Agent warrants to purchase an aggregate of 215 shares of Common Stock at an exercise price of $7.00 per share in partial consideration for its service as placement agent for the Initial Closing.  Such warrants have substantially the same terms as the warrants issued to the Placement Agent in connection with the 2010 Offering, as described above, except that such warrants do not include provisions relating to anti-dilution protection.

d.

On September 10, 2013 the Company granted 26,484 options with an exercise price of $9.50 per share in consideration of investor relations services. The options vest ratably over a period of 12 months from the date of grant and will expire on the fifth anniversary thereof, subject to certain limitations. In connection with this grant the Company recorded during 2013 non-cash compensation expenses amounting to $16,657. At December 31, 2013 fair value per option of $2.52 was estimated using the Black-Scholes option pricing model with the following assumptions: dividend yield of 0%, expected volatility of 105.14%, risk free interest rate of 0.12%, stock price of $8.50 and exercise price of $9.50.

2

Grants to employees

a.

During 2005-2006, Integrity Israel granted to two individuals (an officer and a director), options exercisable into 24,394 shares of NIS 0.01 par value of Integrity Israel.  The exercise price of each option was $3.49 (with respect to 4,486 options) and $3.84 (with respect to 19,908 options).  The vesting period was three years with respect to the 4,486 options and two months with respect to the 19,908 options. The 19,908 options were forfeited. The total non-cash compensation recorded with respect to such grants was $45,291, $2,435 and $203 for the years 2007, 2006 and 2005, respectively.  The fair value of the grants, which was estimated using Black-Scholes option pricing model, was based, among other factors, on the most recent share price with respect to the relevant grant date.

Following the merger with Integrity Israel, the options were replaced with options of the Company.

b.

In August 2007, Integrity Israel's Board of Directors ("Integrity Israel's Board") approved a stock option plan ("Integrity Israel's plan") for the grant, without consideration of options exercisable into ordinary shares of NIS 0.01 par value of Integrity Israel to employees, officers and directors of Integrity Israel.  The exercise price and vesting period for each grantee of options was determined by Integrity Israel's Board and specified in such grantee's option agreement.  The options vested over a period of 1-12 quarters based on each grantee's option agreements.  Any option not exercised within 10 years after the date of grant thereof will expire.

In July 2010, following the merger with Integrity Israel, the Company adopted the 2010 Share Incentive Plan (the "2010 Share Incentive Plan"), pursuant to which the Company's Board of Directors is authorized to grant options exercisable into Common Stock of the Company.  The Company has reserved 529,555 shares of Common Stock for issuance under the plan.  The purpose of the 2010 Share Incentive Plan is to offer an incentive to employees, directors, officers, consultants, advisors, suppliers and any other person or entity whose services are considered valuable to the Company, as well as to replace the Integrity Israel Plan and to replace all options granted in the past by Integrity Israel.

Upon the adoption of the 2010 Share Incentive Plan, all options granted under the Integrity Israel's Plan were replaced by options subject to the 2010 Share Incentive Plan on a 1 for 1 basis.

c.

Pursuant to the terms of their respective employment agreements with the Company, in March 2012, the Company issued to Avner Gal, the Company's Chief Executive Officer, and David Malka, the Company's Executive Vice President of Operations, options to purchase up to 264,778 and 79,434 shares of Common Stock, respectively.  The Options are exercisable at an exercise price of $6.25 per share.  The options vested or will vest (as applicable), in 3 equal parts, upon the achievement of each of the following milestones: (i) submission of clinical trials' results to the Notified Body; (ii) receipt of CE mark approval; (iii) receipt of FDA approval.  In the event of a merger and/or acquisition in which one or more of the abovementioned milestones have not yet been met, the options shall be deemed vested on the date of the merger and/or acquisition.  All options granted as described above are subject to the terms of the 2010 Share Incentive Plan.

The total non-cash compensation expenses recorded with respect to such grants amounted to $ 327,663 and $378,072 for the years ending December 31, 2012 and 2011, respectively.  The amount recognized as an expense takes into consideration the actual achievement of the first and second milestones. Approximately $353,000 of deferred compensation costs are expected to be recognized upon receipt of the FDA approval, if and when received. The fair value of the shares was based on the recent share price applicable.

d.

On March 12, 2012, the Company granted to certain employees options to purchase 17,500 shares of Company's Common Stock at an exercise price of $6.25 per share. All options were granted in accordance with and subject to the terms of the Company's 2010 incentive Compensation Plan.  The total non-cash compensation expenses relating to these grants amounted to $18,962 and $21,859, for the years ending December 31, 2013 and 2012, respectively. Approximately $2,500 of deferred compensation costs are expected to be recognized in 2014.

e.

As of December 31, 2013, there are 114,708 shares available for future grants under the 2010 Share Incentive Plan.

The following tables present a summary of the status of the grants to employees, officers and directors as of December 31, 2013 and 2012:

Number

Weighted average exercise price (US$)

Year ended December 31, 2013

Balance outstanding at beginning of year

471,854

5.47

Granted

-

-

Exercised

-

-

Forfeited

(57,007

)

3.48

Balance outstanding at end of the year

414,847

5.74

Balance exercisable at the end of the year

298,910

5.55

Number

Weighted average exercise price (US$)

Year ended December 31, 2012

Balance outstanding at beginning of year

454,354

5.44

Granted

17,500

6.25

Exercised

-

-

Forfeited

-

-

Balance outstanding at end of the year

471,854

5.47

Balance exercisable at the end of the year

321,039

3.12

The aggregate intrinsic value of the awards exercisable as of December 31, 2013, 2012 and 2011 is $882,471, $ 609,706 and $ 368,926, respectively.  The aggregate intrinsic value of the awards outstanding as of December 31, 2013, 2012 and 2011 was $1,143,330, $ 722,817 and $368,926, respectively. For the years 2012 and 2011, these amounts represent the total intrinsic value, based on management's estimate of the Company's stock price of $ 7 less the weighted exercise price. For the year 2013 management's estimate of the Company's stock price of $8.50 was determined based among other factors on the closing sale price for the Common Stock as reported on the OTC Bulletin Board on December 27, 2013, the last reported sale of Common Stock in 2103.

The following tables summarize information about options outstanding at December 31, 2013:

Exercise

Outstanding at December 31, 2013

Weighted average remaining contractual life (years)

Weighted average exercise price

Exercisable at December 31, 2013

Weighted average remaining contractual life (years)

price (US$)

1.72

40,408

3.75

1.72

40,408

3.75

3.49

4,486

1.92

3.48

4,486

1.92

3.63

4,849

3.75

3.63

4,849

3.75

5.52

1,119

5.2

5.52

1,119

5.2

6.03

4,273

5

6.03

4,273

5

6.25

359,712

8.25

6.25

243,775

8.25

414,847

298,910

The fair value of options granted was estimated at the dates of grant using the Black-Scholes option pricing model.  The following are the data and assumptions used:

2013

2012

2011

Dividend yield (%)

-

0

0

Expected volatility (%) (*)

-

50

50

Risk free interest rate (%)

-

2

2

Expected term of options (years) (**)

-

6

6-May

Exercise price (US dollars)

-

6.25

6.25

Stock price (US dollars) (***)

-

6.25

6.25

Fair value (US dollars)

-

3.08

3.08

(*)

Due to the low trading volume of the Company's Common Stock, the expected volatility was based on the historical volatility of the share price of other public companies that operate in the same industry sector as the Company.

(**)

Due to the fact that the Company does not have sufficient historical exercise data, the expected term was determined based on the "simplified method" in accordance with Staff Accounting Bulletin No. 110.

(***)

The fair value of the share was based on the most recent share prices, as applicable to each grant.

C.

Convertible notes

1

In April 2010, the Company issued Secured Notes ("Senior Notes") in the aggregate initial principal amount of $ 999,000 together with rights to acquire Common Stock following the reorganization and merger described in Note 1.  The principal amount of the notes, together with any interest accrued but unpaid thereon, and any fees and charges, are referred to collectively as the "Outstanding Amount" of such Senior Notes.

The Senior Notes provided for an interest rate of 9% per annum and were due and payable on the first to occur of (a) the date of the closing of the Company's next Qualified Financing (as defined therein); or (b) August 9, 2010, provided that the holders of Senior Notes were permitted to extend the date in clause (b) by up to 60 days with respect to all of the Senior Notes (the "Maturity Date").  Interest on the Senior Notes was to be paid on the Maturity Date if such interest was not exchanged for Common Stock in the manner described above.

Immediately after the initial closing of the 2010 Offering, each purchaser of a Senior Note (each a "Senior Note Purchaser") was entitled to receive Common Stock issued and sold at the closing of the 2010 Offering in accordance with the following:

(i)

If the Senior Note Purchaser elected, to be repaid under its Senior Note in shares of Common Stock in lieu of any cash, such Senior Note Purchaser received the number of shares of Common Stock equal to the quotient obtained by dividing (i) 200% of the unpaid portion of the Outstanding Amount of such Senior Note Purchaser's Senior Note by (ii) the offering price per share of the Common Stock, rounded to the nearest whole share; or

(ii)

If the Senior Note Purchaser did not make the election in clause (i) above, such Senior Note Purchaser instead received the number of shares of Common Stock equal to the quotient obtained by dividing (i) 100% of the unpaid portion of the Outstanding Amount of such Senior Note Purchaser's Senior Note by (ii) the offering price per share of the Common Stock, rounded to the nearest whole share, in addition to a cash payment equal to the Outstanding Amount of such Senior Note Purchaser's Senior Note pursuant to the terms thereof.

The original amount of the Senior Notes $ 999,000, which entitled the holders of the Senior Notes to an either cash or stock settlement at a price per share equal to the fair value of the share that would be determined at the offering, represented stock-settled debt under the provisions of ASC Topic 47-20, "Debt-Debt with Conversion and Other Options".  Due to the terms of the conversion price, the Company determined that this component did not provide an active beneficial conversion feature.  However, the entitlement of the Senior Note holders to receive a fixed value of Common Stock in an amount equal to 100% of the original amount of the Senior Notes (in addition to the stock settled debt described above), which represented an obligation to issue a variable number of shares under the provisions of ASC Topic 480, "Distinguishing Liabilities for Equity" (totaling $999,000), was recognized as a stock-based interest compensation (which was included among financing expenses, net), over the term of the Senior Notes (April 2010 - August 2010).

On December 16, 2010, the Company completed an initial closing of the 2010 Offering, at which the Company issued 87,977 shares of Common Stock to certain holders of Senior Notes, who held an amount of $ 549,797 (including unpaid interest) and which elected to be repaid in shares.  The remaining amount of the Senior Notes, $ 527,396 (including unpaid interest), was settled in cash.

In addition, the Company issued 171,208 shares of Common Stock to the holders of Senior Notes as a repayment of the obligation to issue a variable number of shares.  The fair value of the shares ($1,069,244) represents 100% of the original amount of the Senior Notes and interest accumulated up to the date of the initial closing of the 2010 Offering.

The Company issued to the Placement Agent warrants to purchase an aggregate of 25,919 shares of Common Stock with an exercise price of $ 6.25 and in addition was required to pay the Placement Agent $ 129,870 in cash (see Note 9C).

2

In November 2010, Integrity Israel issued Unsecured Junior Promissory Notes ("Junior Notes") in the aggregate initial principal amount of $ 170,000 (of which $ 25,000 was received in 2011).  The Junior Promissory Notes were substantially similar to the Senior Notes, except that immediately after the initial closing of the 2010 Offering, each holder of Junior Promissory Notes was entitled to receive the number of shares of Common Stock equal to the quotient obtained by dividing (i) 200% of the Outstanding Amount of such holder's Junior Promissory Note by (ii) the price per share of the Common Stock in the 2010 Offering, rounded to the nearest whole share.  The entitlement to receive a fixed value of Common Stock sold at the closing of the 2010 Offering in an amount equal to 200% of the original amount of the Junior Notes was recognized as an obligation to issue a variable number of shares under the provisions of ASC Topic 480, "Distinguishing Liabilities for Equity", accordingly an amount equal to 100% of the original amount of the Junior Notes was recognized as stock-based interest compensation (which was included among financing expenses, net) over the term of the Junior Notes (November 2010 - December 2010).

On December 16, 2010, the Company completed an initial closing of the 2010 Offering, at which, 54,792 shares of Common Stock were issued to the purchasers of the Junior Promissory Notes pursuant to the terms and in full repayment of such Junior Promissory Notes.  The fair value of the shares ($ 345,100) represented 200% of the original amount of the Senior Notes and interest accumulated up to the date of the initial closing of the 2010 Offering.

The Company issued to the Placement Agent, warrants to purchase an aggregate of 5,480 shares of Common Stock with an exercise price of $ 6.25 and in addition was required to pay $ 77,292 in cash (see Note 9C).

D.

On December 16, 2010, the Company completed an initial closing of the 2010 Offering at which the Company received an amount of $ 3,016,250 for 482,600 shares of Common Stock, representing a price per share of $ 6.25.  The Company issued to the Placement Agent warrants to purchase an aggregate of 48,260 shares of Common Stock at the initial closing with an exercise price of $ 6.25 and in addition was required to pay the Placement Agent $ 392,112 in cash (see Note 9C).

E.

On December 30, 2010, the Company completed a second closing of the 2010 Offering at which the Company received an amount of $ 300,000 for 48,000 shares of Common Stock, representing a price per share of $ 6.25.  The Company issued to the Placement Agent warrants to purchase an aggregate of 4,800 shares of Common Stock at the second closing with an exercise price of $ 6.25 and in addition was required to pay the Placement Agent $ 39,000 in cash (see Note 9C).

F.

On January 31, 2011, the Company completed a third closing of the 2010 Offering at which the Company received an amount of $ 102,000 for 16,320 shares of Common Stock, representing a price per share of $ 6.25.  The Company issued to the Placement Agent warrants to purchase an aggregate of 1,632 shares of Common Stock at the third closing with an exercise price of $ 6.25 and in addition was required to pay the Placement Agent $ 13,260 in cash (see Note 9C).

G.

On March 31, 2011, the Company completed a fourth closing of the 2010 Offering at which the Company received an amount of $ 567,300 for 90,768 shares of Common Stock, representing a price per share of $ 6.25.  The Company issued to the Placement Agent warrants to purchase an aggregate of 9,077 shares of Common Stock at the fourth closing with an exercise price of $ 6.25 and in addition was required to pay the Placement Agent $ 73,749 in cash (see Note 9C).

H.

On April 29, 2011, the Company completed a fifth closing of the 2010 Offering at which the Company received an amount of $ 250,000 for 40,000 shares of Common Stock, representing a price per share of $ 6.25.  The Company issued to the Placement Agent warrants to purchase an aggregate of 4,000 shares of common-stock at the fifth closing with an exercise price of $ 6.25 and in addition was required to pay the Placement Agent $ 32,500 in cash (see Note 9C).

I.

On May 31, 2011, the Company completed a sixth closing of the 2010 Offering at which the Company received an amount of $ 213,750 for 34,200 shares of Common Stock, representing a price per share of $ 6.25.  The Company issued to the Placement Agent warrants to purchase an aggregate of 3,420 shares of common-stock at the sixth closing with an exercise price of $ 6.25 and in addition was required to pay the Placement Agent $ 27,788 in cash (see Note 9C).

J.

On July 29, 2011, the Company completed a seventh and final closing of the 2010 Offering at which the Company received an amount of $ 1,685,500 for 269,680 shares of Common Stock.  The Company issued to the Placement Agent warrants to purchase an aggregate of 26,968 shares of common-stock at the seventh closing with an exercise price of $ 6.25 and in addition was required to pay the Placement Agent $ 219,115 in cash (see Note 9C).

K.

Purchasers of the Common Stock in the 2010 Offering were entitled to anti-dilution protection until September 1, 2012 for certain issuances of Common Stock by the Company for less than $ 6.25 per share.

L.

On November 19, 2012, the Company issued 165,057 shares of its Common Stock at a price of $7.00 per share, for a total consideration of $1,155,399.  The issuance and sale of such shares constituted the initial closing (the "Initial Closing") of the 2012 Offering, which was originally structured as an offering of up to  785,714 shares of its Common Stock to accredited investors (the "First Closing Purchasers") at a price of $7.00 per share in a private placement transaction. See also Note 10M regarding the conversion of the Common Stock issued in November 2012 into Units.

M.

Subsequent to the Initial Closing, the 2012 Offering was converted from an offering of Common Stock to an offering of Units and, on March 13, 2013, the Company entered into a Securities Purchase Agreement with certain accredited investors (the "Unit Purchasers") pursuant to which the Company issued to the Unit Purchasers an aggregate of 6,300 Units.  The shares of Preferred Stock comprising the Units were convertible into an aggregate of 1,086,178 shares of Common Stock and the Warrants comprising the Units are exercisable into an aggregate of 1,086,178 shares of Common Stock, in each case subject to adjustment as described below. After giving effect to the payment of commissions to the Placement Agent for the offering and the payment of certain offering expenses, the Company received net proceeds from the offering of approximately $5.4 million (See Note 9C).

The issuance and sale of the Units constituted the second and final closing of an offering of the Company's securities in a private placement transaction.   As a result of the conversion of the offering from an offering of Common Stock to an offering of Units, the Company agreed with the Placement Agent that the Company would exchange the shares of Common Stock acquired by each First Closing Purchaser in the Initial Closing for such number of Units equal to the aggregate purchase price paid by such First Closing Purchaser in the Initial Closing (see Note 10L), divided by $1,000, in each case subject to the execution by the First Closing Purchaser of a consent to such modification.  Pursuant to this agreement, on May 13, 2013, the Company cancelled 162,907 of the 165,057 shares of Common Stock issued to the First Closing Purchasers and issued to such purchasers an aggregate of 1,140.35 Units.  These Units included Preferred Stock convertible into an aggregate of 196,597 shares of Common Stock and Warrants exercisable for 196,597 shares of Common Stock.  The total fair value of such Units was equal to the amount originally invested by the First Closing Purchasers that consented to exchange their shares into Units ($1,140,139).  As a result, during 2013, the total fair value of such Units was classified out of stockholders equity and was presented as temporary equity (convertible Preferred Stock) and liability (warrant with down-round provision), as applicable to each instrument.

The Warrants included in the Units have a five-year term commencing on their issuance date. The Warrants are exercisable at any time at an exercise price of $6.96 per share.  The Warrants contain adjustment provisions substantially similar to the adjustment provisions of the Preferred Stock as described above, including provisions requiring an adjustment of the exercise price of the Warrants to the price at which the Company subsequently issues shares or other equity-linked financial instruments, if that price is less than the original exercise price of the Warrants (down-round protection).  In addition, the Warrants provide for protection for a Buy-In on substantially the same terms as described above with respect to the Preferred Stock.  No holder may exercise its Warrants in excess of the Beneficial Ownership Limitation.

In connection with the 2012 Offering the Company incurred a total of $1,479,864 of issuance costs of which $562,805 attributable to non-cash compensation expenses relating to warrants issued to the Placement Agent (See Notes 9C and Note10B.1.c). The average fair value per warrant of $2.19 was estimated using the following assumptions: dividend yield of 1%, expected volatility of 96.66%, risk free interest rate of 0.9%, stock price of $2.77 and exercise price ranging between $5.8-7.0.

The allocation of the issuance proceeds to the Preferred Stock and to the detachable warrants and their respective issuance costs is described in Note 2Q and Note 2R above.

The Company has determined its derivative warrant liability to be a Level 3 fair value measurement and has used the Binomial pricing model to calculate its fair value. Because the warrants contain a price protection feature, the probability that the exercise price of the warrants would decrease as the stock price decreased was incorporated into the valuation calculations.  The key inputs used in the fair value calculations were as follows:

December 31,

2013

Dividend yield (%)

-

Expected volatility (%) (*)

105.14

Risk free interest rate (%)

1.36

Expected term of options (years) (**)

4.2

Exercise price (US dollars)

6.96

Share price (US dollars) (***)

8.5

Fair value (US dollars)

6.405

(*)

Due to the low trading volume of the Company's Common Stock, the expected volatility was based on the historical volatility of the share price of other public companies that operate in the same industry sector as the Company.

(**)

Due to the fact that the Company does not have sufficient historical exercise data, the expected term was determined based on the "simplified method" in accordance with Staff Accounting Bulletin No. 110.

(***)

The fair value per share of the Company's Common Stock as of December 31, 2013 was based on the management's estimate which was based among other factors on the closing price per share of the Company's Common Stock on December 27, 2013, as reported on the OTC Bulletin Board, the last reported sale of Common Stock in 2103.

N.

In connection with the 2012 Offering, the Company also agreed with the placement agent for the offering that, following the closing of the sale of the Units, the Company would issue to the holders of the 1,295,535 shares of Common Stock issued by the Company at a price of $6.25 per share pursuant to the Company's previously completed private placement of Common Stock (accrued during 2011 and 2010) such number of shares of Common Stock as would reduce the per share purchase price paid by such holders for such shares from $6.25 per share to $5.80 per share, in each case subject to the execution by the holder of a consent to such modification. As a result, upon the receipt of executed consents to modification from all such holders, the Company has issued or will be required to issue to such holders an aggregate of 100,526 shares of Common Stock.  As of September 30, 2013, the Common Stock had an estimated fair value of $2.77 per share.  The issuance of such shares has been accounted for as a stock dividend.  Accordingly, the fair value of the shares was charged to the "deficit accumulated during development stage" against additional paid in capital.

O.

During the year ended December 31, 2013 23.2 shares of Preferred Stock were converted into 4,000 shares of Common Stock.   The conversion resulted in an increase to Stockholders equity and a decrease in temporary equity of $23,200, representing the fair value of the Preferred Stock at the closing date.

RESEARCH_AND_DEVELOPMENT_EXPEN

RESEARCH AND DEVELOPMENT EXPENSES, NET	12 Months Ended
	Dec. 31, 2013
RESEARCH AND DEVELOPMENT EXPENSES, NET [Abstract]	'
RESEARCH AND DEVELOPMENT EXPENSES, NET	'
	NOTE 11	-	RESEARCH AND DEVELOPMENT EXPENSES, NET
			US dollars
			Year ended December 31,						Cumulative period from September 30, 2001 (date of inception) through December 31,
			2013		2012		2011		2013
	Salaries and related expenses			1,293,067		1,289,890		1,194,170		7,429,979
	Professional fees			247,888		262,752		210,674		1,953,393
	Materials			154,522		166,480		60,360		800,717
	Depreciation			32,858		25,546		22,835		284,079
	Travel expenses			43,131		4,116		119,498		391,314
	Vehicle maintenance			35,955		33,035		33,856		310,410
	Other			179,333		138,871		147,908		1,386,728
				1,986,754		1,920,690		1,789,301		12,556,620
	Less:Grants from the OCS (*)			-		-		-		(93,462	)
				1,986,754		1,920,690		1,789,301		12,463,158
		(*)	See Note 9A.

GENERAL_AND_ADMINISTRATIVE_EXP

GENERAL AND ADMINISTRATIVE EXPENSES	12 Months Ended
	Dec. 31, 2013
GENERAL AND ADMINISTRATIVE EXPENSES [Abstract]	'
GENERAL AND ADMINISTRATIVE EXPENSES	'
	NOTE 12	-	GENERAL AND ADMINISTRATIVE EXPENSES
			US dollars
			Year ended December 31,						Cumulative period from September 30, 2001 (date of inception) through December 31
			2013		2012		2011		2013
	Salaries and related expenses			260,276		255,839		162,221		946,871
	Professional fees			562,435		392,832		336,308		2,446,290
	Travel & expenses			128,095		119,757		-		247,852
	Vehicle maintenance			26,529		14,506		5,534		80,491
	Other			63,805		69,974		40,082		334,278
				1,041,140		852,908		544,145		4,055,782

FINANCING_INCOME_EXPENSES_NET

FINANCING (INCOME) EXPENSES, NET	12 Months Ended
	Dec. 31, 2013
FINANCING (INCOME) EXPENSES, NET [Abstract]	'
FINANCING (INCOME) EXPENSES, NET	'
	NOTE 13	-	FINANCING (INCOME) EXPENSES, NET
			US dollars
			Year ended December 31,								Cumulative period from September 30, 2001 (date of inception) through December 31
			2013		2012			2011			2013
	Israeli CPI linkage difference on principal of loans from stockholders			14,382		9,849			24,934			201,280
	Exchange rate differences			94,815		18,147			(4,638	)		346,859
	Warrants with down round protection			6,251,242		(35,892	)		-			6,215,350
	Issuance cost allocated to warrants with down-round protection			390,928		-			-			390,928
	Stock-based interest compensation to holders of convertible notes			-		-			-			1,214,943
	Interest expenses on credit from banks and other			17,592		6,605			10,597			(1,521	)
	Interest expenses and other, related to convertible notes			-		-			-			200,812
				6,768,959		(1,291	)		30,893			8,568,651

INCOME_TAX

INCOME TAX	12 Months Ended
	Dec. 31, 2013
INCOME TAX [Abstract]	'
INCOME TAX	'
	NOTE 14	-	INCOME TAX
		A.	Measurement of results for tax purposes under the Israeli Income Tax (Inflationary Adjustments) Law, 1985 (the "Inflationary Adjustment Law")
		Commencing January 1, 2008, the results of operations of Integrity Israel for tax purposes are measured on a nominal basis.
		B.	Reduction in Israeli corporate tax rates
		As part of the Economic Efficiency Law (Legislative Amendments for the Implementation of the Economic Plan for the years 2009 and 2010) - 2009 (the "Arrangements Law") (hereinafter - the "Economic Efficiency Law for 2009"), article 126 of the Income Tax Ordinance (New Version) - 1961 was amended, whereby the corporate tax rate would be reduced so that in 2011 the corporate tax rate was 24% and in the years 2012 - 2016 the tax rate was supposed to be gradually reduced.
		On December 6, 2011, the Law for the Change in the Tax Burden (Legislative Amendments) - 2011 was published.  As part of this law, among other things, commencing from 2012, the blueprint for the reduction in corporate tax rates set out in the Economic Efficiency Law for 2009 was cancelled and the corporate tax rate was increased to 25%.  Commencing in 2012, in addition, the tax rate on capital gains in real terms and the tax rate applicable to betterment in real terms were increased to 25%.
		On July 30, 2013, the Israeli parliament approved the Law for the Change in National Priorities (Legislative Amendments to Achieve Budgetary Goals for 2013 and 2014) - 2013 (hereinafter - the "Law for the Change in National Priorities"), which, among other things increased the standard Israeli corporate income tax rate from 25% to 26.5% effective as of January 1, 2014.
		C.	Tax assessments
		The Company and Integrity Israel have not received final tax assessments since their inception.
		D.	Carryforward tax losses
		As of December 31, 2013, the Company had cumulative net operating losses (NOL) for US federal purposes of approximately $1.4 million that will expire between 2030-2033. Integrity Israel has losses carry forward balances for Israeli income tax purposes of nearly $ 15.5 million to offset against future taxable income for an indefinite period of time.
		E.	The following is a reconciliation between the theoretical tax on pre-tax income, at the tax rate applicable to the Company (federal tax rate) and the tax expense reported in the financial statements:
			US dollars
			Year ended December 31,
			2013			2012			2011
	Pretax loss			(9,796,853	)		(2,772,307	)		(2,364,339	)
	Federal tax rate			35	%		35	%		35	%
	Income tax benefit computed at the ordinary tax rate			(3,428,899	)		(970,307	)		(827,519	)
	Non-deductible expenses			21,250			4,553			4,885
	Stock-based compensation			10,570			122,333			132,325
	Amortization of warrants with down round protection			2,324,760			-			-
	Tax in respect of differences in corporate tax rates			253,942			277,231			236,434
	Losses and timing differences in respect of which no deferred taxes assets were recognized			818,377			566,190			453,875
				-			-			-
		F.	Deferred taxes result principally from temporary differences in the recognition of certain revenue and expense items for financial and income tax reporting purposes.  Significant components of the Group's future tax assets are as follows:
			US dollars
			December 31,
			2013			2012			2011
	Composition of deferred tax assets:
	Provision for employee-related obligation			33,629			47,440			42,137
	Non-capital loss carry forwards			4,364,466			3,496,123			2,890,426
	Valuation allowance			(4,398,095	)		(3,543,563	)		(2,932,563	)
				-			-			-

LOSS_PER_SHARE

LOSS PER SHARE	12 Months Ended
	Dec. 31, 2013
LOSS PER SHARE [Abstract]	'
LOSS PER SHARE	'
	NOTE 15	-	LOSS PER SHARE
		The loss and the weighted average number of shares used in computing basic and diluted loss per share for the years ended December 31, 2013, 2012 and 2011, are as follows:
			US dollars
			Year ended December 31,
			2013		2012		2011
	Loss for the year			9,796,853		2,772,307		2,364,339
	Stock dividend to certain Common Stockholder			278,263		-		-
	Dividend on Preferred Stock			288,247		-		-
				10,363,363		2,772,307		2,364,339
			Number of shares
			Year ended December 31,
			2013		2012		2011
	Weighted average number of shares used in the computation of basic and diluted earnings per share			5,325,714		5,314,800		5,091,330
	Total weighted average number of ordinary shares related to outstanding Preferred Stock, options and warrants excluded from the calculations of diluted loss per share (*)			2,813,493		600,232		582,732
		(*)	All outstanding stock options, warrants and Preferred Stock have been excluded from the calculation of the diluted net loss per share for all the reported periods, since the effect of the shares issuable with respect of these instruments was anti-dilutive.

RELATED_PARTIES

RELATED PARTIES	12 Months Ended
	Dec. 31, 2013
RELATED PARTIES [Abstract]	'
RELATED PARTIES	'
	NOTE 16	-	RELATED PARTIES
		A.	Avner Gal, the beneficial owner of approximately 10.71% of the Company's outstanding Common Stock as of December 31, 2013, entered into an employment agreement with Integrity Israel in July 2010 pursuant to which Mr. Gal agreed to continue to serve as the chief executive officer and managing director of Integrity Israel.  The agreement was approved by the board of directors and stockholders of Integrity Israel. Mr. Gal's employment agreement provides for an annual salary of approximately $138,500 (NIS 480,000) and an annual bonus to be determined by the board of directors and an additional sum provided that Mr. Gal reaches certain milestones approved by the board, as well as the payment of certain social and insurance benefits and the use of a car.  The agreement also provides for a renegotiation of Mr. Gal's annual salary on the one-year anniversary thereof and the renegotiation of Mr. Gal's bonus formula once Integrity Israel has begun commercialization of its products.  The agreement is terminable by either party on 180 days notice, immediately by Integrity Israel with the payment of an amount equal to 180 days of annual salary, or immediately by Integrity Israel for cause (as defined in the agreement) without the payment of severance.  Mr. Gal is subject to a non-compete and a confidentiality agreement during the term of the agreement and for one year thereafter.
		B.	David Malka, the beneficial owner of 4.45% of the Company's outstanding Common Stock as of December 31, 2013, entered into an employment agreement with Integrity Israel in July 2010 pursuant to which Mr. Malka agreed to continue to serve as the vice president of operations of Integrity Israel.  The agreement was approved by the board of directors and stockholders of Integrity Israel. Mr. Malka's employment agreement provides for an annual salary of approximately $69,150 (NIS 240,000) and an annual bonus to be determined by the Board of Directors in its sole discretion and an additional sum provided that Mr. Malka reaches certain milestones approved by the Board, as well as the payment of certain social and insurance benefits and the use of a group three car.  The agreement also provided for a renegotiation of Mr. Malka's annual salary on the one-year anniversary thereof and the renegotiation of Mr. Malka's bonus formula once Integrity Israel has begun commercialization of its products.  The agreement is terminable by either party on 90 days notice, immediately by Integrity Israel with the payment of an amount equal to 90 days of annual salary, or immediately by Integrity Israel for cause (as defined in the agreement) without the payment of severance.  Mr. Malka is subject to a non-compete and confidentiality agreement during the term of the agreement and for one year thereafter.

SUMMARY_OF_SIGNIFICANT_ACCOUNT1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policy)	12 Months Ended
	Dec. 31, 2013
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]	'
Use of estimates in the preparation of financial statements	'
		A.	Use of estimates in the preparation of financial statements
		The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the consolidated financial statements, and the reported amounts of expenses during the reporting periods. Actual results could differ from those estimates. As applicable to these consolidated financial statements, the most significant estimates and assumptions relate to (a) the allocation of the proceeds and the related issuance costs of Units consisting of convertible Preferred Stock and warrants with down round protection, (b) the fair value estimate of the warrants with the down-round protection and (c) the going concern assumptions.
Functional currency	'
		B.	Functional currency
		The functional currency of the Company is the US dollar, which is the currency of the primary economic environment in which it operates.  In accordance with ASC 830, "Foreign Currency Matters" (ASC 830), balances denominated in or linked to foreign currency are stated on the basis of the exchange rates prevailing at the applicable balance sheet date.  For foreign currency transactions included in the statement of operations, the exchange rates applicable on the relevant transaction dates are used.  Gains or losses arising from changes in the exchange rates used in the translation of such transactions are carried as financing income or expenses. The functional currency of Integrity Israel is the New Israeli Shekel ("NIS") and its financial statements are included in consolidation, based on translation into US dollars.  Accordingly, assets and liabilities were translated from NIS to US dollars using year-end exchange rates, and income and expense items were translated at average exchange rates during the year. Gains or losses resulting from translation adjustments are reflected in stockholders' equity (deficit), under "accumulated other comprehensive income (loss)".
			Year ended December 31,
			2013		2012		2011
	Official exchange rate of NIS 1 to US dollar			0.288		0.268		0.262
Principles of consolidation	'
		C.	Principles of consolidation
		The consolidated financial statements include the accounts of the Company and its subsidiary. All intercompany balances and transactions have been eliminated in consolidation.
		As described in Note 1A above, the merger of Integrity Israel has been accounted for in a manner similar to a pooling of interests at historical cost.
Cash and cash equivalents	'
		D.	Cash and cash equivalents
		The Group considers all short-term investments, which are highly liquid investments with original maturities of three months or less at the date of purchase, to be cash equivalents.
Property and equipment, net	'
		E.	Property and equipment, net
		1	Property and equipment are stated at cost, net of accumulated depreciation.  Depreciation is calculated using the straight-line method over the estimated useful lives of the assets.  When an asset is retired or otherwise disposed of, the related carrying value and accumulated depreciation are removed from the respective accounts and the net difference less any amount realized from disposition is reflected in the statements of operations.
		2	Rates of depreciation:
		%
	Computers	33
	Furniture and office equipment	15-Jul
	Leasehold improvements	Shorter of lease term
		and 10 years
Impairment of long-lived assets	'
		F.	Impairment of long-lived assets
		The Group's long-lived assets are reviewed for impairment in accordance with ASC 360, "Property, Plant and Equipment", whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.  Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the asset.  If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds its fair value.  To date the Group did not incur any material impairment losses.
Deferred income taxes	'
		G.	Deferred income taxes
		The Group accounts for income taxes in accordance with ASC 740, "Income Taxes". Accordingly, deferred income taxes are determined utilizing the asset and liability method based on the estimated future tax effects of differences between the financial accounting and the tax bases of assets and liabilities under the applicable tax law.  Deferred tax balances are computed using the enacted tax rates expected to be in effect when these differences reverse.  Valuation allowances in respect of deferred tax assets are provided for, if necessary, to reduce deferred tax assets to amounts more likely than not to be realized.
		The Group accounts for uncertain tax positions in accordance with ASC Topic 740-10, which prescribes detailed guidance for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in an enterprise's financial statements. According to ASC Topic 740-10, tax positions must meet a more-likely-than-not recognition threshold. The Group's accounting policy is to classify interest and penalties relating to uncertain tax positions under income taxes, however the Group did not recognize such items in its fiscal 2013, 2012 and 2011 financial statements and did not recognize any liability with respect to unrecognized tax position in its balance sheet.
Liability for employee rights upon retirement	'
		H.	Liability for employee rights upon retirement
		Integrity Israel's liability for employee rights upon retirement with respect to its Israeli employees is calculated pursuant to the Israeli Severance Pay Law, based on the most recent salary of each employee multiplied by the number of years of employment as of the balance sheet date. Employees are entitled to one month's salary for each year of employment, or ratable portion thereof for periods less than one year. Integrity Israel makes monthly deposits to insurance policies and severance pay funds.
		The deposited funds may be withdrawn upon the fulfillment of Integrity Israel's severance obligations pursuant to Israeli severance pay laws or labor agreements with its employees.  The value of the deposited funds is based on the cash surrender value of these policies, and includes immaterial profits or losses.
		Commencing 2011, Integrity Israel's agreements with its Israeli employees are in accordance with Section 14 of the Severance Pay Law. Payments in accordance with Section 14 release the employer from any future severance payments in respect of those employees. Related obligations and liabilities under Section 14 are not recorded as an asset or as a liability in the Company's balance sheet.
		Severance expenses for the year ended December 31, 2013, 2012 and 2011 amounted to $91,588, $78,556 and $42,358, respectively.
Research and development expenses	'
		I.	Research and development expenses
			Research and development expenses are charged to operations as incurred.  Grants received by Integrity Israel from the Government of Israel through the Office of the Chief Scientist of the Ministry of Industry, Trade and Labor (the "OCS") for development of approved projects were recognized as a reduction of expenses when the related costs were incurred.
Royalty-bearing grants	'
		J.	Royalty-bearing grants
		Royalty-bearing grants from the OCS for funding approved research and development projects are recognized at the time Integrity Israel is entitled to such grants, on the basis of the costs incurred and reduce research and development costs.  The cumulative research and development grants received by Integrity Israel from inception through December 2004 amounted to $93,462.  Integrity Israel has not received any research and development grants since December 2004.
		As of December 31, 2013, 2012 and 2011, the Group did not accrue or pay any royalties to the OCS.
Loss per share	'
		K.	Loss per share
		Basic loss per share is computed by dividing loss for the period by the weighted average number of shares of Common Stock outstanding during the period. Securities that may participate in dividends with the Common Stock (such as the convertible Preferred Stock) are included in the computation of basic earnings per share using the two class method. However, in periods of net loss, such participating securities are not included since the holders of such securities do not have a contractual obligation to share the losses of the Company.
		In computing diluted earnings per share, basic earnings per share are adjusted to reflect the potential dilution that could occur upon the exercise of options or warrants issued or granted using the "treasury stock method" and upon the conversion of Preferred Stock using the "if-converted method", if their effect is dilutive.
Stock-based compensation	'
		L.	Stock-based compensation
		The Group measures and recognizes the compensation expense for all equity-based payments to employees based on their estimated fair values in accordance with ASC 718, "Compensation-Stock Compensation". Share-based payments including grants of stock options and shares are recognized in the statement of operations as an operating expense, based on the fair value of the award at the date of grant.  The fair value of options is estimated using the Black-Scholes option-pricing model and the fair value of share grants is estimated using recent transaction prices.  The Group has expensed compensation costs, net of estimated forfeitures, applying the accelerated vesting method, over the requisite service period or over the implicit service period when a performance condition affects the vesting, and it is considered probable that the performance condition will be achieved.
		Share-based payments awarded to consultants (non-employees) are accounted for in accordance with ASC Topic 505-50, "Equity-Based Payments to Non-Employees".
Fair value of financial instruments	'
		M.	Fair value of financial instruments
		ASC Topic 825-10, "Financial Instruments" defines financial instruments and requires disclosure of the fair value of financial instruments held by the Group. The Group considers the carrying amount of cash and cash equivalents, other current assets, credit from banking institutions, accounts payable and other current liabilities balances, to approximate their fair values because of the short period of time between the origination of such instruments and their expected realization.  The warrants with down-round protection represent a derivative liability and therefore are measured and presented on the balance sheet at fair value. The fair value measurement of the warrants is classified as level 3. The Group did not estimate the fair value of the long-term loans from stockholders since their repayment schedule has not yet been determined.
Convertible notes	'
		N.	Convertible notes
		The Group considered the provisions of ASC Topic 815, "Derivatives and Hedging", and determined that the conversion feature should not be separated from the host instrument.  Furthermore, the Group applied ASC Topic 470-20, "Debt - Debt with Conversion and Other Options" which clarifies the accounting for instruments with beneficial conversion features or contingency adjustable conversion ratios.  The Group has determined that the convertible notes did not include a beneficial conversion feature. The entire balance of the convertible notes (which were issued during fiscal year 2010) was either repaid in cash or converted into Common Stock during fiscal year 2010 (see also Note 10C).
Concentrations of credit risk	'
		O.	Concentrations of credit risk
		Financial instruments that potentially subject the Group to concentrations of credit risk consist primarily of cash and cash equivalents.  Cash and cash equivalents are deposited with major banks in Israel and the United States of America. Management believes that such financial institutions are financially sound and, accordingly, minimal credit risk exists with respect to these financial instruments. The Group does not have any significant off-balance-sheet concentration of credit risk, such as foreign exchange contracts, option contracts or other foreign hedging arrangements.
Contingencies	'
		P.	Contingencies
		The Group records accruals for loss contingencies arising from claims, litigation and other sources when it is probable that a liability has been incurred and the amount can be reasonably estimated. These accruals are adjusted periodically as assessments change or additional information becomes available. Legal costs incurred in connection with loss contingencies are expensed as incurred.
Temporary equity	'
		Q.	Temporary equity
		As more fully described in Note 10M, in March 2013 the Company issued convertible Preferred Stock which provide a liquidation preference and certain redemption rights for the benefit of the holders of such Preferred Stock upon the occurrence of certain events, some of which are not within the Company's control.  Accordingly, the convertible Preferred Stock is presented as temporary equity.
		Upon initial recognition, the Preferred Stock was measured based on the "residual approach". Accordingly, the amount allocated to the Preferred Stock was based on the gross proceeds (including the gross proceeds to the Company from the issuance of Common Stock that was subsequently replaced with Units - See Note 10L), net of the fair value of the detachable warrants and net of the direct issuance expenses that were allocated to the Preferred Stock.
		Since at the commitment date, the exercise price of the conversion feature (based on the effective conversion rate of the Preferred Stock into Common Stock) was higher than the estimated fair value of the Company's Common Stock, it was determined that the conversion feature was not beneficial.
		On each balance sheet date, the Company's management assesses the probability of redemption of the Preferred Stock. In the event that management determines such redemption to be probable as of an applicable balance sheet date, the Company will recognize a liability in an amount equal to the aggregate redemption price of the Preferred Stock. In addition, upon such determination, the difference between the amount that was allocated to the Preferred Stock (after deduction of issuance expenses) and such redemption amount will be accreted over the period beginning on the date that it becomes probable that the instrument will become redeemable and ending on the earliest redemption date.
Warrants with down-round protection	'
		R.	Warrants with "down-round" protection
		The Company considered the provisions of ASC 815-40, "Derivatives and Hedging: Contracts in Entity's Own Equity", with respect to the detachable warrants that were issued to the Unit Purchasers, as described in Note 10M, and determined that as a result of the "down-round" protection that would adjust the exercise price of the warrants to the price at which the Company subsequently issues shares or other equity-linked financial instruments, if that price is less than the original exercise price of the warrants, such warrants cannot be considered as indexed to the Company's own stock. Accordingly, the warrants were recognized as derivative liability at their fair value on initial recognition. In subsequent periods, the warrants are marked to market with the changes in fair value recognized as financing expense or income in the consolidated statement of operations. The direct issuance expenses that were allocated to the detachable warrants were expensed as incurred.
Recently issued accounting pronouncements	'
		S.	Recently issued accounting pronouncements
		1	ASC Topic 220, "Comprehensive Income"
		Effective January 1, 2013, the Group adopted Accounting Standard Update No. 2013-02 "Comprehensive Income (Topic 220) - Reporting of Amounts Reclassified out of Accumulated Other Comprehensive Income" (ASU 2013-02). ASU 2013-02 requires an entity to provide information about amounts reclassified out of accumulated other comprehensive income.
		According to ASU 2013-02, significant items that are required under U.S. GAAP to be reclassified to net income in their entirety shall be presented by the respective line items of net income either on the face of the financial statements or in the footnotes. Items that are not required under U.S. GAAP to be reclassified to net income in their entirety are required to be cross-referenced to other disclosures required under U.S. GAAP that provide additional detail about those amounts. The adoption of ASU 2013-02 did not have a material impact on the financial position or results of operations of the Group.
		2	ASC Topic 210, "Balance Sheet"
		Effective January 1, 2013, the Group adopted Accounting Standard Update (ASU) 2011-11, "Balance Sheet (Topic 210) - Disclosures about Offsetting Assets and Liabilities" (ASU 2011-11). ASU 2011-11 enhances disclosures about financial instruments and derivative instruments that are either offset in accordance with the Accounting Standards Codification or are subject to an enforceable master netting arrangement or similar agreement.
		The amended guidance became effective, in a retrospective manner to all comparative periods presented, for annual reporting periods beginning on or after January 1, 2013, and interim periods within those annual periods.
		The adoption of ASU 2011-11 did not have a material impact on the financial position or results of operations of the Group.
		3	ASC Topic 830, Foreign "Currency Matters"
		In March 2013, the FASB issued Accounting Standards Update 2013-5, Foreign Currency Matters (Topic 830): Parent's Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity ("ASU 2013-5").
		ASU 2013-5 clarifies among other things that, when a reporting entity (parent) ceases to have a controlling financial interest in a subsidiary or group of assets that is a business (other than a sale of in-substance real estate or conveyance of oil and gas mineral rights) within a foreign entity, the parent is required to apply the guidance in Subtopic 830-30 to release any related cumulative translation adjustment into net income. Accordingly, the cumulative translation adjustment should be released into net income only if the sale or transfer results in the complete or substantially complete liquidation of the foreign entity in which the subsidiary or group of assets had resided.
		For public companies, the amendments in this Update will be effective prospectively for fiscal years (and interim reporting periods within those years) beginning after December 15, 2013. The amendments should be applied prospectively to derecognition events occurring after the effective date. Prior periods should not be adjusted. Early adoption is permitted. If an entity elects to early adopt the amendments, it should apply them as of the beginning of the entity's fiscal year of adoption. The adoption of the standard is not expected to have a material impact on the Group's consolidated results of operations and financial condition.

SUMMARY_OF_SIGNIFICANT_ACCOUNT2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Dec. 31, 2013
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]	'
Schedule of Official Exchange Rate	'
			Year ended December 31,
			2013		2012		2011
	Official exchange rate of NIS 1 to US dollar			0.288		0.268		0.262
Schedule of Property and Equipment, Rates of Depreciation	'
	Rates of depreciation:
		%
	Computers	33
	Furniture and office equipment	15-Jul
	Leasehold improvements	Shorter of lease term
		and 10 years

OTHER_CURRENT_ASSETS_Tables

OTHER CURRENT ASSETS (Tables)	12 Months Ended
	Dec. 31, 2013
OTHER CURRENT ASSETS [Abstract]	'
Schedule of Other Current Assets	'
			US dollars
			December 31,
			2013		2012
	Prepaid expenses			29,044		29,460
	Government Institution (*)			64,008		52,012
				93,052		81,472
		(*)	Represents amounts advanced by Integrity Israel to the Israeli tax authorities or amounts owed to Integrity Israel by the Israeli Value Added Tax authorities.

PROPERTY_AND_EQUIPMENT_NET_Tab

PROPERTY AND EQUIPMENT, NET (Tables)	12 Months Ended
	Dec. 31, 2013
PROPERTY AND EQUIPMENT, NET [Abstract]	'
Schedule of Property and Equipment	'
		US dollars
		December 31,
		2013			2012
	Computers		110,930			85,517
	Furniture and office equipment		168,957			114,982
	Leasehold improvements		25,761			23,953
			305,648			224,452
	Less - accumulated depreciation		(198,439	)		(154,252	)
			107,209			70,200

ACCOUNTS_PAYABLE_Tables

ACCOUNTS PAYABLE (Tables)	12 Months Ended
	Dec. 31, 2013
ACCOUNTS PAYABLE [Abstract]	'
Schedule of Accounts Payable	'
		US dollars
		December 31,
		2013		2012
	Open accounts		8,085		96,870
	Checks payable		41,702		25,667
			49,787		122,537

OTHER_CURRENT_LIABILITIES_Tabl

OTHER CURRENT LIABILITIES (Tables)	12 Months Ended
	Dec. 31, 2013
OTHER CURRENT LIABILITIES [Abstract]	'
Schedule of Other Current Liabilities	'
		US dollars
		December 31,
		2013		2012
	Employees and related institutions		217,027		184,394
	Accrued expenses and other		44,093		113,595
			261,120		297,989

WARRANT_WITH_DOWNROUND_PROTECT1

WARRANT WITH DOWN-ROUND PROTECTION, TEMPORARY EQUITY AND SHARE CAPITAL (Tables)	12 Months Ended
	Dec. 31, 2013
WARRANT WITH DOWN-ROUND PROTECTION, TEMPORARY EQUITY AND SHARE CAPITAL [Abstract]	'
Schedule of Stock Grants Activity	'
		The following tables present a summary of the status of the grants to employees, officers and directors as of December 31, 2013 and 2012:
			Number				Weighted average exercise price (US$)
	Year ended December 31, 2013
	Balance outstanding at beginning of year			471,854				5.47
	Granted			-				-
	Exercised			-				-
	Forfeited			(57,007	)			3.48
	Balance outstanding at end of the year			414,847				5.74
	Balance exercisable at the end of the year			298,910				5.55
			Number				Weighted average exercise price (US$)
	Year ended December 31, 2012
	Balance outstanding at beginning of year			454,354				5.44
	Granted			17,500				6.25
	Exercised			-				-
	Forfeited			-				-
	Balance outstanding at end of the year			471,854				5.47
	Balance exercisable at the end of the year			321,039				3.12
Schedule of Stock Grants, by Exercise Price Range	'
		The following tables summarize information about options outstanding at December 31, 2013:
	Exercise				Outstanding at December 31, 2013				Weighted average remaining contractual life (years)				Weighted average exercise price		Exercisable at December 31, 2013		Weighted average remaining contractual life (years)
	price (US$)
		1.72				40,408				3.75				1.72		40,408		3.75
		3.49				4,486				1.92				3.48		4,486		1.92
		3.63				4,849				3.75				3.63		4,849		3.75
		5.52				1,119				5.2				5.52		1,119		5.2
		6.03				4,273				5				6.03		4,273		5
		6.25				359,712				8.25				6.25		243,775		8.25
						414,847										298,910
Schedule of Assumptions Used to Value Options	'
		The fair value of options granted was estimated at the dates of grant using the Black-Scholes option pricing model.  The following are the data and assumptions used:
			2013				2012				2011
	Dividend yield (%)			-				0				0
	Expected volatility (%) (*)			-				50				50
	Risk free interest rate (%)			-				2				2
	Expected term of options (years) (**)			-				6				6-May
	Exercise price (US dollars)			-				6.25				6.25
	Stock price (US dollars) (***)			-				6.25				6.25
	Fair value (US dollars)			-				3.08				3.08
		(*)	Due to the low trading volume of the Company's Common Stock, the expected volatility was based on the historical volatility of the share price of other public companies that operate in the same industry sector as the Company.
		(**)	Due to the fact that the Company does not have sufficient historical exercise data, the expected term was determined based on the "simplified method" in accordance with Staff Accounting Bulletin No. 110.
		(***)	The fair value of the share was based on the most recent share prices, as applicable to each grant.
Schedule of Fair Value Assumptions Used	'
	The key inputs used in the fair value calculations were as follows:
			December 31,
			2013
	Dividend yield (%)			-
	Expected volatility (%) (*)			105.14
	Risk free interest rate (%)			1.36
	Expected term of options (years) (**)			4.2
	Exercise price (US dollars)			6.96
	Share price (US dollars) (***)			8.5
	Fair value (US dollars)			6.405
		(*)	Due to the low trading volume of the Company's Common Stock, the expected volatility was based on the historical volatility of the share price of other public companies that operate in the same industry sector as the Company.
		(**)	Due to the fact that the Company does not have sufficient historical exercise data, the expected term was determined based on the "simplified method" in accordance with Staff Accounting Bulletin No. 110.
		(***)	The fair value per share of the Company's Common Stock as of December 31, 2013 was based on the management's estimate which was based among other factors on the closing price per share of the Company's Common Stock on December 27, 2013, as reported on the OTC Bulletin Board, the last reported sale of Common Stock in 2103.

RESEARCH_AND_DEVELOPMENT_EXPEN1

RESEARCH AND DEVELOPMENT EXPENSES, NET (Tables)	12 Months Ended
	Dec. 31, 2013
RESEARCH AND DEVELOPMENT EXPENSES, NET [Abstract]	'
Schedule of Research and Development Expenses	'
			US dollars
			Year ended December 31,						Cumulative period from September 30, 2001 (date of inception) through December 31,
			2013		2012		2011		2013
	Salaries and related expenses			1,293,067		1,289,890		1,194,170		7,429,979
	Professional fees			247,888		262,752		210,674		1,953,393
	Materials			154,522		166,480		60,360		800,717
	Depreciation			32,858		25,546		22,835		284,079
	Travel expenses			43,131		4,116		119,498		391,314
	Vehicle maintenance			35,955		33,035		33,856		310,410
	Other			179,333		138,871		147,908		1,386,728
				1,986,754		1,920,690		1,789,301		12,556,620
	Less:Grants from the OCS (*)			-		-		-		(93,462	)
				1,986,754		1,920,690		1,789,301		12,463,158
		(*)	See Note 9A.

GENERAL_AND_ADMINISTRATIVE_EXP1

GENERAL AND ADMINISTRATIVE EXPENSES (Tables)	12 Months Ended
	Dec. 31, 2013
GENERAL AND ADMINISTRATIVE EXPENSES [Abstract]	'
Schedule of General and Administrative Expenses	'
		US dollars
		Year ended December 31,						Cumulative period from September 30, 2001 (date of inception) through December 31
		2013		2012		2011		2013
	Salaries and related expenses		260,276		255,839		162,221		946,871
	Professional fees		562,435		392,832		336,308		2,446,290
	Travel & expenses		128,095		119,757		-		247,852
	Vehicle maintenance		26,529		14,506		5,534		80,491
	Other		63,805		69,974		40,082		334,278
			1,041,140		852,908		544,145		4,055,782

FINANCING_INCOME_EXPENSES_NET_

FINANCING (INCOME) EXPENSES, NET (Tables)	12 Months Ended
	Dec. 31, 2013
FINANCING (INCOME) EXPENSES, NET [Abstract]	'
Schedule of Financing (Income) Expenses, Net	'
		US dollars
		Year ended December 31,								Cumulative period from September 30, 2001 (date of inception) through December 31
		2013		2012			2011			2013
	Israeli CPI linkage difference on principal of loans from stockholders		14,382		9,849			24,934			201,280
	Exchange rate differences		94,815		18,147			(4,638	)		346,859
	Warrants with down round protection		6,251,242		(35,892	)		-			6,215,350
	Issuance cost allocated to warrants with down-round protection		390,928		-			-			390,928
	Stock-based interest compensation to holders of convertible notes		-		-			-			1,214,943
	Interest expenses on credit from banks and other		17,592		6,605			10,597			(1,521	)
	Interest expenses and other, related to convertible notes		-		-			-			200,812
			6,768,959		(1,291	)		30,893			8,568,651

INCOME_TAX_Tables

INCOME TAX (Tables)	12 Months Ended
	Dec. 31, 2013
INCOME TAX [Abstract]	'
Reconciliation of Statutory Tax Rate to the Effective Income Tax Rate	'
	The following is a reconciliation between the theoretical tax on pre-tax income, at the tax rate applicable to the Company (federal tax rate) and the tax expense reported in the financial statements:
		US dollars
		Year ended December 31,
		2013			2012			2011
	Pretax loss		(9,796,853	)		(2,772,307	)		(2,364,339	)
	Federal tax rate		35	%		35	%		35	%
	Income tax benefit computed at the ordinary tax rate		(3,428,899	)		(970,307	)		(827,519	)
	Non-deductible expenses		21,250			4,553			4,885
	Stock-based compensation		10,570			122,333			132,325
	Amortization of warrants with down round protection		2,324,760			-			-
	Tax in respect of differences in corporate tax rates		253,942			277,231			236,434
	Losses and timing differences in respect of which no deferred taxes assets were recognized		818,377			566,190			453,875
			-			-			-
Schedule of Deferred Taxes	'
	Deferred taxes result principally from temporary differences in the recognition of certain revenue and expense items for financial and income tax reporting purposes.  Significant components of the Group's future tax assets are as follows:
		US dollars
		December 31,
		2013			2012			2011
	Composition of deferred tax assets:
	Provision for employee-related obligation		33,629			47,440			42,137
	Non-capital loss carry forwards		4,364,466			3,496,123			2,890,426
	Valuation allowance		(4,398,095	)		(3,543,563	)		(2,932,563	)
			-			-			-

LOSS_PER_SHARE_Tables

LOSS PER SHARE (Tables)	12 Months Ended
	Dec. 31, 2013
LOSS PER SHARE [Abstract]	'
Schedule of Loss and Weighted Average Number of Shares	'
		The loss and the weighted average number of shares used in computing basic and diluted loss per share for the years ended December 31, 2013, 2012 and 2011, are as follows:
			US dollars
			Year ended December 31,
			2013		2012		2011
	Loss for the year			9,796,853		2,772,307		2,364,339
	Stock dividend to certain Common Stockholder			278,263		-		-
	Dividend on Preferred Stock			288,247		-		-
				10,363,363		2,772,307		2,364,339
			Number of shares
			Year ended December 31,
			2013		2012		2011
	Weighted average number of shares used in the computation of basic and diluted earnings per share			5,325,714		5,314,800		5,091,330
	Total weighted average number of ordinary shares related to outstanding Preferred Stock, options and warrants excluded from the calculations of diluted loss per share (*)			2,813,493		600,232		582,732
		(*)	All outstanding stock options, warrants and Preferred Stock have been excluded from the calculation of the diluted net loss per share for all the reported periods, since the effect of the shares issuable with respect of these instruments was anti-dilutive.
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	'
			Number of shares
			Year ended December 31,
			2013		2012		2011
	Weighted average number of shares used in the computation of basic and diluted earnings per share			5,325,714		5,314,800		5,091,330
	Total weighted average number of ordinary shares related to outstanding Preferred Stock, options and warrants excluded from the calculations of diluted loss per share (*)			2,813,493		600,232		582,732
		(*)	All outstanding stock options, warrants and Preferred Stock have been excluded from the calculation of the diluted net loss per share for all the reported periods, since the effect of the shares issuable with respect of these instruments was anti-dilutive.

GENERAL_Details

GENERAL (Details) (USD $)

12 Months Ended

147 Months Ended

0 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2010

Dec. 31, 2013

Dec. 31, 2009

Dec. 31, 2008

Dec. 31, 2007

Dec. 31, 2006

Dec. 31, 2005

Dec. 31, 2004

Dec. 31, 2003

Dec. 31, 2002

Sep. 29, 2001

13-May-13

14-May-13

14-May-13

Scenario, Plan [Member]

Scenario, Plan [Member]

Scenario, Plan [Member]

Purchasers of Previously Issued Common Stock [Member]

GENERAL [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Deficit accumulated during the development stage

($25,653,190)

($15,289,826)

'

'

($25,653,190)

'

'

'

'

'

'

'

'

'

'

'

'

Stockholders' deficit

-11,063,118

-503,069

968,239

598,139

-11,063,118

-775,742

49,750

542,217

1,776,235

-270,063

-487,627

-388,181

-22,856

'

'

'

'

Cumulative operating cash flow

-3,217,767

-2,296,989

-1,916,113

'

-14,791,827

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from issuance of Common Stock, net of issuance expenses

'

917,179

2,401,214

'

11,323,559

'

'

'

'

'

'

'

'

'

'

'

'

Stock split conversion ratio

'

'

'

2.1363

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from convertible preferred stock and warrants

$5,400,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Class of Stock [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock issued, shares

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,295,535

2,824,471

2,150

Shares convertible into

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,284,925

'

Number of shares covered by warrants

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,539,546

'

SUMMARY_OF_SIGNIFICANT_ACCOUNT3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $)	12 Months Ended				147 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2004	Dec. 31, 2013
Functional currency	'	'	'	'	'
Official exchange rate of NIS 1 to US dollar	0.288	0.268	0.262	'	'
Liability for employee rights upon retirement	'	'	'	'	'
Severance expenses	$91,588	$78,556	$42,358	'	'
Royalty-bearing grants	'	'	'	'	'
Research and development grants	'	'	'	$93,462	$93,462
Computers [Member]	'	'	'	'	'
Property and equipment, net	'	'	'	'	'
%	33.00%	'	'	'	'
Furniture and Office Equipment [Member] | Minimum [Member]	'	'	'	'	'
Property and equipment, net	'	'	'	'	'
%	7.00%	'	'	'	'
Furniture and Office Equipment [Member] | Maximum [Member]	'	'	'	'	'
Property and equipment, net	'	'	'	'	'
%	15.00%	'	'	'	'
Leasehold Improvements [Member] | Maximum [Member]	'	'	'	'	'
Property and equipment, net	'	'	'	'	'
Useful life	'10 years	'	'	'	'

OTHER_CURRENT_ASSETS_Details

OTHER CURRENT ASSETS (Details) (USD $)	Dec. 31, 2013		Dec. 31, 2012
OTHER CURRENT ASSETS [Abstract]	'		'
Prepaid expenses	$29,044		$29,460
Government Institution	64,008	[1]	52,012	[1]
Total other current assets	$93,052		$81,472
[1]	Represents amounts advanced by Integrity Israel to the Israeli tax authorities or amounts owed to Integrity Israel by the Israeli Value Added Tax authorities.

PROPERTY_AND_EQUIPMENT_NET_Det

PROPERTY AND EQUIPMENT, NET (Details) (USD $)	12 Months Ended			147 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2013
Property, Plant and Equipment [Line Items]	'	'	'	'
Property and equipment, gross	$305,648	$224,452	'	$305,648
Less - accumulated depreciation	-198,439	-154,252	'	-198,439
Property and equipment, net	107,209	70,200	'	107,209
Depreciation	33,684	25,546	23,045	191,717
Purchase of property and equipment	64,252	11,347	54,619	284,372
Computers [Member]	'	'	'	'
Property, Plant and Equipment [Line Items]	'	'	'	'
Property and equipment, gross	110,930	85,517	'	110,930
Furniture and Office Equipment [Member]	'	'	'	'
Property, Plant and Equipment [Line Items]	'	'	'	'
Property and equipment, gross	168,957	114,982	'	168,957
Leasehold Improvements [Member]	'	'	'	'
Property, Plant and Equipment [Line Items]	'	'	'	'
Property and equipment, gross	$25,761	$23,953	'	$25,761

ACCOUNTS_PAYABLE_Details

ACCOUNTS PAYABLE (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
ACCOUNTS PAYABLE [Abstract]	'	'
Open accounts	$8,085	$96,870
Checks payable	41,702	25,667
Total accounts payable	$49,787	$122,537

OTHER_CURRENT_LIABILITIES_Deta

OTHER CURRENT LIABILITIES (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
OTHER CURRENT LIABILITIES [Abstract]	'	'
Employees and related institutions	$217,027	$184,394
Accrued expenses and other	44,093	113,595
Total other current liabilities	$261,120	$297,989

LINE_OF_CREDIT_Details

LINE OF CREDIT (Details)	Dec. 31, 2013	Dec. 31, 2013
	USD ($)	ILS
LINE OF CREDIT [Abstract]	'	'
Amount of unutilized credit line	$86,430	300,000

LONGTERM_LOANS_FROM_STOCKHOLDE1

LONG-TERM LOANS FROM STOCKHOLDERS (Details)	12 Months Ended
	Dec. 31, 2013
LONG-TERM LOANS FROM STOCKHOLDERS [Abstract]	'
Percent of future sales to be transferred to lenders	10.00%

COMMITMENTS_AND_CONTINGENT_LIA1

COMMITMENTS AND CONTINGENT LIABILITIES (Details)

12 Months Ended

147 Months Ended

12 Months Ended

12 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2004

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2010

Dec. 31, 2010

Dec. 31, 2010

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2010

Dec. 31, 2010

Dec. 31, 2010

Dec. 31, 2004

Dec. 31, 2004

Dec. 31, 2013

Dec. 31, 2013

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

ILS

Agreement with Placement Agent [Member]

Agreement with Placement Agent [Member]

Agreement with Placement Agent [Member]

December Offering [Member]

December Offering [Member]

December Offering [Member]

2012 Offering [Member]

2012 Offering [Member]

Registration Payment Commission Rate [Member]

Registration Payment Arrangement Management Fee [Member]

Registration Payment Arrangement Expense Allowance [Member]

Payment of Royalties to OCS [Member]

Payment of Royalties to OCS [Member]

Payment of Royalties to OCS [Member]

Arbitration Proceedings with Shareholder [Member]

sqft

sqft

USD ($)

USD ($)

USD ($)

Minimum [Member]

Maximum [Member]

Common Stock [Member]

Preferred Stock [Member]

USD ($)

ILS

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Commitments and Legal Proceedings:

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Research and development grants

'

'

'

$93,462

$93,462

'

'

'

'

'

'

'

'

'

'

'

'

$93,462

420,000

'

'

Percent of budget funded by grant

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

60.00%

60.00%

'

'

Maximum royalties payable

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

93,462

'

'

'

Royalty on the sale of any product developed, minimum

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3.00%

3.00%

'

'

Royalty on the sale of any product developed, maximum

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

5.00%

5.00%

'

'

Contingent liabilities with respect to the grants

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

93,462

'

Ownership and anti-dilution percentage at issue

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

18.00%

Lease Disclosures:

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Office space leased

3,100

'

'

'

3,100

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Monthly lease payment

3,300

'

'

'

3,300

11,500

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

The Offering:

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of shares to be issued in offering

'

'

'

'

'

'

'

'

'

'

560,000

2,000,000

'

'

'

'

'

'

'

'

'

Value of shares to be issued in offering

'

'

'

'

'

'

'

'

'

'

3,500,000

12,500,000

5,000,000

7,500,000

'

'

'

'

'

'

'

Commission fee percentage

'

'

'

'

'

'

'

'

'

13.00%

'

'

'

'

7.00%

3.00%

3.00%

'

'

'

'

Payments made to agent

'

'

'

'

'

'

$820,493

$150,202

$366,412

'

'

'

'

'

'

'

'

'

'

'

'

WARRANT_WITH_DOWNROUND_PROTECT2

WARRANT WITH DOWN-ROUND PROTECTION, TEMPORARY EQUITY AND SHARE CAPITAL (Description of Rights Attached to Stock) (Details) (USD $)	12 Months Ended
	Dec. 31, 2013
Temporary Equity [Line Items]	'
Preferred dividends paid	$288,248
Convertible Preferred Stock [Member]	'
Temporary Equity [Line Items]	'
Conversion price	$5.80
Dividend rate, percentages	5.00%
Convertible preferred stock, stated value	$1,000
Dividend requirement threshold	110.00%
Dividend late fee rate	9.00%
Convertible preferred stock, stock price trigger	11.6
Convertible preferred stock, trading volume trigger	$100,000
Preferred stock, liquidating damages	$10
Convertible preferred stock, percentage dividend regulation	15.00%
Convertible preferred stock, maximum beneficial ownership	4.99%
Convertible preferred stock, maximum beneficial ownership, subject to term	9.99%

WARRANT_WITH_DOWNROUND_PROTECT3

WARRANT WITH DOWN-ROUND PROTECTION, TEMPORARY EQUITY AND SHARE CAPITAL (Grants to Non-Employees) (Details)

12 Months Ended

12 Months Ended

12 Months Ended

0 Months Ended

12 Months Ended

0 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2005

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Mar. 13, 2013

Mar. 13, 2013

Dec. 31, 2007

Dec. 31, 2006

Dec. 31, 2005

Dec. 31, 2008

Dec. 31, 2006

Dec. 31, 2013

Dec. 31, 2013

Jul. 29, 2011

31-May-11

Apr. 29, 2011

Mar. 31, 2011

Jan. 31, 2011

Dec. 30, 2010

Dec. 16, 2010

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2010

13-May-13

Sep. 10, 2013

USD ($)

USD ($)

ILS

2012 Offering [Member]

2012 Offering [Member]

2012 Offering [Member]

Warrants Issued to Placement Agent, Tranche One [Member]

Warrants Issued to Placement Agent, Tranche Two [Member]

Consultants [Member]

Consultants [Member]

Consultants [Member]

Investor Finders [Member]

Investor Finders [Member]

Investor Finders [Member]

Investor Finders [Member]

Placement Agent [Member]

Placement Agent [Member]

Placement Agent [Member]

Placement Agent [Member]

Placement Agent [Member]

Placement Agent [Member]

Placement Agent [Member]

Placement Agent [Member]

Placement Agent [Member]

Placement Agent [Member]

Andrew Garrett, Inc. [Member]

Investor Relations Services Provider [Member]

USD ($)

Minimum [Member]

Maximum [Member]

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Grant Date 1 [Member]

Grant Date 2 [Member]

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Share-based Goods and Nonemployee Services Transaction [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of securities issued

'

'

'

'

'

'

'

'

'

'

144,250

8,989

45,531

'

'

26,968

3,420

4,000

9,077

1,632

4,800

48,260

256,554

45,097

84,459

215

26,484

Common Stock, par value per share

$0.00

$0.00

0.01

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Service period

'

'

'

'

'

'

'

'

'

'

'2 months to 2 years

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Total issuance costs

'

'

'

$1,479,864

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Non-cash compensation expense

$562,805

'

'

$562,805

'

'

'

'

$123,625

$229,564

$175,516

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$16,657

Exercise price

'

'

'

'

'

'

'

'

'

'

'

$5.52

$4.30

'

'

$6.25

$6.25

$6.25

$6.25

$6.25

$6.25

$6.25

'

'

'

'

$9.50

Options forfeited

'

'

'

'

'

'

'

'

'

'

'

'

'

17,657

5,365

'

'

'

'

'

'

'

'

'

'

'

'

Warrant exercise price

'

'

'

'

'

'

6.96

5.8

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

6.25

6.25

7

'

Fair value

'

'

'

$2.19

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$2.52

Assumed dividend yield

'

'

'

1.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.00%

Expected volatility

'

'

'

96.66%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

105.14%

Assumed risk free interest rate

'

'

'

0.90%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.12%

Assumed exercise price

'

'

'

'

$5.80

$7

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$9.50

Share price

'

'

'

$2.77

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$8.50

WARRANT_WITH_DOWNROUND_PROTECT4

WARRANT WITH DOWN-ROUND PROTECTION, TEMPORARY EQUITY AND SHARE CAPITAL (Grants to Employees Narrative) (Details) (USD $)

12 Months Ended

0 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

0 Months Ended

Dec. 31, 2007

Dec. 31, 2007

Dec. 31, 2007

Mar. 12, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2007

Dec. 31, 2006

Dec. 31, 2005

Dec. 31, 2006

Dec. 31, 2006

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Mar. 12, 2012

Mar. 12, 2012

Integrity Israel Plan [Member]

Integrity Israel Plan [Member]

Integrity Israel Plan [Member]

2010 Share Incentive Plan [Member]

2010 Share Incentive Plan [Member]

2010 Share Incentive Plan [Member]

2010 Share Incentive Plan [Member]

Options Granted to Officer and Director [Member]

Options Granted to Officer and Director [Member]

Options Granted to Officer and Director [Member]

Options Granted to Officer and Director, Tranche One [Member]

Options Granted to Officer and Director, Tranche Two [Member]

Options Issued to Employees [Member]

Options Issued to Employees [Member]

Options Issued to Employees [Member]

Options Issued to Employees [Member]

Options Issued to Employees [Member]

Options Issued to Employees [Member]

Options Issued to Employees [Member]

Options Issued to Employees [Member]

Minimum [Member]

Maximum [Member]

Grants to Messrs. Gal and Malka [Member]

Grants to Messrs. Gal and Malka [Member]

Grants to Messrs. Gal and Malka [Member]

Chief Executive Officer [Member]

Executive Vice President [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Options granted during period

'

'

'

17,500

'

'

'

'

24,394

'

4,486

19,908

'

17,500

'

'

'

'

264,778

79,434

Exercise price

'

'

'

$6.25

'

'

'

'

'

'

$3.49

$3.84

'

$6.25

'

'

'

'

$6.25

$6.25

Vesting period

'

'3 months

'3 years

'

'

'

'

'

'

'

'3 years

'2 months

'

'

'

'

'

'

'

'

Non-cash compensation expense

'

'

'

$50,000

$327,663

$21,859

'

$45,291

$2,435

$203

'

'

$18,962

$21,859

'

$327,663

$378,072

'

'

'

Maximum contractual term

'10 years

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock reserved for issuance

'

'

'

'

529,555

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Options granted at period end

'

'

'

'

'

'

'

'

'

'

'

'

414,847

471,854

454,354

'

'

'

'

'

Shares available for future grants

'

'

'

'

114,708

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Unrecognized compensation costs

'

'

'

'

4,000

'

'

'

'

'

'

'

2,500

'

'

'

'

353,000

'

'

Aggregate intrinsic value of the awards exercisable

'

'

'

'

882,471

609,706

368,926

'

'

'

'

'

'

'

'

'

'

'

'

'

Aggregate intrinsic value of the awards outstanding

'

'

'

'

$1,143,330

$722,817

$368,926

'

'

'

'

'

'

'

'

'

'

'

'

'

Share price

'

'

'

'

$8.50

$7

$7

'

'

'

'

'

'

[1]

$6.25

[1]

$6.25

[1]

'

'

'

'

'

[1]

The fair value of the share was based on the most recent share prices, as applicable to each grant.

WARRANT_WITH_DOWNROUND_PROTECT5

WARRANT WITH DOWN-ROUND PROTECTION, TEMPORARY EQUITY AND SHARE CAPITAL (Schedule of Status of Grants to Employees) (Details) (Options Issued to Employees [Member], USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Options Issued to Employees [Member]	'	'
Number	'	'
Balance outstanding at beginning of period	471,854	454,354
Granted	'	17,500
Exercised	'	'
Forfeited	-57,007	'
Balance outstanding at end of the period	414,847	471,854
Balance exercisable at the end of the period	298,910	321,039
Weighted average exercise price (US$)	'	'
Balance outstanding at beginning of period	$5.47	$5.44
Granted	'	$6.25
Exercised	'	'
Forfeited	$3.48	'
Balance outstanding at end of the period	$5.74	$5.47
Balance exercisable at the end of the period	$5.55	$3.12

WARRANT_WITH_DOWNROUND_PROTECT6

WARRANT WITH DOWN-ROUND PROTECTION, TEMPORARY EQUITY AND SHARE CAPITAL (Schedule of Information about Options Outstanding) (Details) (USD $)	12 Months Ended
	Dec. 31, 2013
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Outstanding at December 31	414,847
Exercisable at December 31	298,910
1.72 [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Minimum exercise price	$1.72
Maximum exercise price	$1.72
Outstanding at December 31	40,408
Weighted average remaining contractual life years	'3 years 9 months
Weighted average exercise price	$1.72
Exercisable at December 31	40,408
Weighted average exercise price	$3.75
3.49 [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Minimum exercise price	$3.49
Maximum exercise price	$3.49
Outstanding at December 31	4,486
Weighted average remaining contractual life years	'1 year 11 months 1 day
Weighted average exercise price	$3.48
Exercisable at December 31	4,486
Weighted average exercise price	$1.92
3.63 [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Minimum exercise price	$3.63
Maximum exercise price	$3.63
Outstanding at December 31	4,849
Weighted average remaining contractual life years	'3 years 9 months
Weighted average exercise price	$3.63
Exercisable at December 31	4,849
Weighted average exercise price	$3.75
5.52 [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Minimum exercise price	$5.52
Maximum exercise price	$5.52
Outstanding at December 31	1,119
Weighted average remaining contractual life years	'5 years 2 months 12 days
Weighted average exercise price	$5.52
Exercisable at December 31	1,119
Weighted average exercise price	$5.20
6.03 [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Minimum exercise price	$6.03
Maximum exercise price	$6.03
Outstanding at December 31	4,273
Weighted average remaining contractual life years	'5 years
Weighted average exercise price	$6.03
Exercisable at December 31	4,273
Weighted average exercise price	$5
6.25 [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Minimum exercise price	$6.25
Maximum exercise price	$6.25
Outstanding at December 31	359,712
Weighted average remaining contractual life years	'8 years 3 months
Weighted average exercise price	$6.25
Exercisable at December 31	243,775
Weighted average exercise price	$8.25

WARRANT_WITH_DOWNROUND_PROTECT7

WARRANT WITH DOWN-ROUND PROTECTION, TEMPORARY EQUITY AND SHARE CAPITAL (Schedule of Assumptions Used to Value Options) (Details) (Options Issued to Employees [Member], USD $)	12 Months Ended
	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2011
The following are the data and assumptions used:	'		'		'
Dividend yield	'		0.00%		0.00%
Expected volatility	'	[1]	50.00%	[1]	50.00%	[1]
Risk free interest rate	'		2.00%		2.00%
Expected term of options	'	[2]	'6 years	[2]	'
Exercise price	'		$6.25		$6.25
Share price	'	[3]	$6.25	[3]	$6.25	[3]
Fair value	'		$3.08		$3.08
Minimum [Member]	'		'		'
The following are the data and assumptions used:	'		'		'
Expected term of options	'		'		'5 years	[2]
Maximum [Member]	'		'		'
The following are the data and assumptions used:	'		'		'
Expected term of options	'		'		'6 years	[2]
[1]	Due to the low trading volume of the Company's Common Stock, the expected volatility was based on the historical volatility of the share price of other public companies that operate in the same industry sector as the Company.
[2]	Due to the fact that the Company does not have sufficient historical exercise data, the expected term was determined based on the "simplified method" in accordance with Staff Accounting Bulletin No. 110.
[3]	The fair value of the share was based on the most recent share prices, as applicable to each grant.

WARRANT_WITH_DOWNROUND_PROTECT8

WARRANT WITH DOWN-ROUND PROTECTION, TEMPORARY EQUITY AND SHARE CAPITAL (Convertible Notes) (Details) (USD $)

12 Months Ended

147 Months Ended

0 Months Ended

12 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Jul. 29, 2011

31-May-11

Apr. 29, 2011

Mar. 31, 2011

Jan. 31, 2011

Dec. 30, 2010

Dec. 16, 2010

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2010

Dec. 31, 2010

Dec. 31, 2010

Dec. 31, 2010

Dec. 31, 2010

Dec. 31, 2011

Dec. 31, 2010

Dec. 31, 2010

Dec. 31, 2010

Placement Agent [Member]

Placement Agent [Member]

Placement Agent [Member]

Placement Agent [Member]

Placement Agent [Member]

Placement Agent [Member]

Placement Agent [Member]

Placement Agent [Member]

Placement Agent [Member]

Placement Agent [Member]

Secured Convertible Notes [Member]

Secured Convertible Notes [Member]

Secured Convertible Notes [Member]

Secured Convertible Notes [Member]

Unsecured Junior Promissory Notes [Member]

Unsecured Junior Promissory Notes [Member]

Unsecured Junior Promissory Notes [Member]

Unsecured Junior Promissory Notes [Member]

Placement Agent [Member]

Conversion of Secured Notes [Member]

Conversion of Secured Notes Variable Portion [Member]

Placement Agent [Member]

Conversion of Junior Promissory Notes [Member]

Debt Instrument [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Principal amount of debt

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$999,000

'

'

'

'

$170,000

'

'

Proceeds from issuance of convertible notes

'

'

'

1,144,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

25,000

'

'

'

Debt interest rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

9.00%

'

'

'

'

'

'

'

Debt maturity date

'

'

'

'

'

'

'

'

'

'

'

'

'

'

9-Aug-10

'

'

'

'

'

'

'

Numerator in obtaining repayment amount, if repaid in stock

'

'

'

'

'

'

'

'

'

'

'

'

'

'

200.00%

'

'

'

'

200.00%

'

'

Numerator in obtaining repayment amount, if repaid in cash

'

'

'

'

'

'

'

'

'

'

'

'

'

'

100.00%

'

'

'

'

100.00%

'

'

Percent of notes recognized as stock-based compensation

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

100.00%

'

'

Shares issued for debt conversion

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

87,977

171,208

'

'

'

54,792

Principle amount of debt converted into shares

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

549,797

'

'

'

'

'

Fair value of stock issued for debt

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,069,244

'

'

'

345,100

Repayments of convertible notes

'

'

'

527,396

'

'

'

'

'

'

'

'

'

'

527,396

'

'

'

'

'

'

'

Repurchase percentage of debt

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

100.00%

'

'

'

200.00%

Number of warrants issued

'

'

'

'

26,968

3,420

4,000

9,077

1,632

4,800

48,260

256,554

45,097

84,459

'

25,919

'

'

'

'

5,480

'

Warrant exercise price

'

'

'

'

'

'

'

'

'

'

'

'

6.25

6.25

'

6.25

'

'

'

'

6.25

'

Payments of costs to placement agent

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$129,870

'

'

'

'

$77,292

'

WARRANT_WITH_DOWNROUND_PROTECT9

WARRANT WITH DOWN-ROUND PROTECTION, TEMPORARY EQUITY AND SHARE CAPITAL (Disclosures about Stock Issuances) (Details) (USD $)

0 Months Ended

1 Months Ended

15 Months Ended

0 Months Ended

12 Months Ended

Nov. 19, 2012

Jul. 29, 2011

31-May-11

Apr. 29, 2011

Mar. 31, 2011

Jan. 31, 2011

Dec. 30, 2010

Dec. 16, 2010

Oct. 07, 2008

Sep. 27, 2008

Dec. 14, 2006

Oct. 05, 2006

Aug. 15, 2006

Jun. 30, 2006

Jun. 16, 2006

Mar. 31, 2006

Jan. 26, 2006

31-May-05

Apr. 05, 2005

Jan. 14, 2005

Nov. 25, 2004

Mar. 16, 2004

Dec. 31, 2010

Jan. 31, 2009

Dec. 31, 2002

Jul. 29, 2011

31-May-11

Apr. 29, 2011

Mar. 31, 2011

Jan. 31, 2011

Dec. 30, 2010

Dec. 16, 2010

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2010

Placement Agent [Member]

Placement Agent [Member]

Placement Agent [Member]

Placement Agent [Member]

Placement Agent [Member]

Placement Agent [Member]

Placement Agent [Member]

Placement Agent [Member]

Placement Agent [Member]

Placement Agent [Member]

SHARE CAPITAL [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Amount of issuance

$1,155,399

$1,685,500

$213,750

$250,000

$567,300

$102,000

$300,000

$3,016,250

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Shares sold

165,057

269,680

34,200

40,000

90,768

16,320

48,000

482,600

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common stock issued, price per share

$7

$6.25

$6.25

$6.25

$6.25

$6.25

$6.25

$6.25

$5.52

$5.52

$4.31

$4.31

$3.91

$3.63

$3.63

$3.63

$1.47

$3.37

$1.72

$1.72

$1.72

$1.76

$6.25

$6.02

$0.00

'

'

'

'

'

'

'

'

'

'

Number of shares offered

785,714

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Goods and Nonemployee Services Transaction [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of warrants issued

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

26,968

3,420

4,000

9,077

1,632

4,800

48,260

256,554

45,097

84,459

Exercise price

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$6.25

$6.25

$6.25

$6.25

$6.25

$6.25

$6.25

'

'

'

Payments of issuance costs

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$219,115

$27,788

$32,500

$73,749

$13,260

$39,000

$392,112

'

'

'

Recovered_Sheet1

WARRANT WITH DOWN-ROUND PROTECTION, TEMPORARY EQUITY AND SHARE CAPITAL (Convertible Preferred Stock) (Details) (USD $)

0 Months Ended

12 Months Ended

0 Months Ended

0 Months Ended

13-May-13

Mar. 13, 2013

Nov. 19, 2012

Jul. 29, 2011

31-May-11

Apr. 29, 2011

Mar. 31, 2011

Jan. 31, 2011

Dec. 30, 2010

Dec. 16, 2010

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

13-May-13

14-May-13

14-May-13

Dec. 31, 2013

Dec. 31, 2013

13-May-13

Mar. 13, 2013

Common Stock [Member]

Retained Earnings [Member]

Scenario, Plan [Member]

Scenario, Plan [Member]

Purchasers of Previously Issued Common Stock [Member]

Warrants Issued under Securities Purchase Agreement [Member]

Warrants Issued under Second Closing of Securities Purchase Agreement [Member]

Convertible Preferred Stock [Member]

Convertible Preferred Stock [Member]

Scenario, Plan [Member]

Temporary Equity [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of units sold

1,140.35

6,300

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Shares convertible into

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,284,925

'

'

'

196,597

1,086,178

Number of shares covered by warrants

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,539,546

'

1,086,178

196,597

'

'

Warrant exercise price

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

6.96

'

'

'

Proceeds from convertible preferred stock and warrants

'

'

'

'

'

'

'

'

'

'

$5,400,000

'

'

'

'

'

'

'

'

'

Shares sold

'

'

165,057

269,680

34,200

40,000

90,768

16,320

48,000

482,600

'

'

'

'

'

'

'

'

'

'

Cancellation of shares, shares

162,907

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Value of temporary equity reclassified

1,140,139

'

'

'

'

'

'

'

'

'

-23,200

'

'

'

'

'

'

'

'

'

Stock price at which stock dividend is declared

'

'

'

'

'

'

'

'

'

'

$5.80

'

'

'

'

'

'

'

'

'

Stock dividend

'

'

'

'

'

'

'

'

'

'

'

'

$278,263

'

'

'

'

'

'

'

Stock dividend, shares

'

'

'

'

'

'

'

'

'

'

'

100,526

'

'

'

'

'

'

'

'

Stock issued, shares

'

'

'

'

'

'

'

'

'

'

'

'

'

1,295,535

2,824,471

2,150

'

'

'

'

Number of preferred shares converted

'

'

'

'

'

'

'

'

'

'

23.2

'

'

'

'

'

'

'

'

'

Stock issued upon conversion

'

'

'

'

'

'

'

'

'

'

4,000

'

'

'

'

'

'

'

'

'

Recovered_Sheet2

WARRANT WITH DOWN-ROUND PROTECTION, TEMPORARY EQUITY AND SHARE CAPITAL (Schedule of Warrant Inputs) (Details) (USD $)	12 Months Ended
	Dec. 31, 2013
Common Stock [Member]	'
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]	'
Share price	$8.50	[1]
Warrant [Member]	'
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]	'
Dividend yield	'
Expected volatility	105.14%	[2]
Risk free interest rate	1.36%
Expected term of options	'4 years 2 months 12 days	[3]
Exercise price	$6.96
Fair value	$6.41
[1]	The fair value per share of the Company's Common Stock as of December 31, 2013 was based on the management's estimate which was based among other factors on the closing price per share of the Company's Common Stock on December 27, 2013, as reported on the OTC Bulletin Board, the last reported sale of Common Stock in 2103.
[2]	Due to the low trading volume of the Company's Common Stock, the expected volatility was based on the historical volatility of the share price of other public companies that operate in the same industry sector as the Company.
[3]	Due to the fact that the Company does not have sufficient historical exercise data, the expected term was determined based on the "simplified method" in accordance with Staff Accounting Bulletin No. 110.

RESEARCH_AND_DEVELOPMENT_EXPEN2

RESEARCH AND DEVELOPMENT EXPENSES, NET (Details) (USD $)	12 Months Ended				147 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2004	Dec. 31, 2013
Total research and development expenses	$1,986,754	$1,920,690	$1,789,301	'	$12,556,620
Less: Grants from the OCS	'	'	'	-93,462	-93,462
Total research and development expenses, net	1,986,754	1,920,690	1,789,301	'	12,463,158
Research and Development Expense [Member]	'	'	'	'	'
Salaries and related expenses	1,293,067	1,289,890	1,194,170	'	7,429,979
Professional fees	247,888	262,752	210,674	'	1,953,393
Materials	154,522	166,480	60,360	'	800,717
Depreciation	32,858	25,546	22,835	'	284,079
Travel & expenses	43,131	4,116	119,498	'	391,314
Vehicle maintenance	35,955	33,035	33,856	'	310,410
Other	$179,333	$138,871	$147,908	'	$1,386,728

GENERAL_AND_ADMINISTRATIVE_EXP2

GENERAL AND ADMINISTRATIVE EXPENSES (Details) (USD $)	12 Months Ended			147 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2013
Total general and administrative expenses	$1,041,140	$852,908	$544,145	$4,055,782
General and Administrative Expense [Member]	'	'	'	'
Salaries and related expenses	260,276	255,839	162,221	946,871
Professional fees	562,435	392,832	336,308	2,446,290
Travel & expenses	128,095	119,757	'	247,852
Vehicle maintenance	26,529	14,506	5,534	80,491
Other	$63,805	$69,974	$40,082	$334,278

FINANCING_INCOME_EXPENSES_NET_1

FINANCING (INCOME) EXPENSES, NET (Details) (USD $)	12 Months Ended			147 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2013
FINANCING (INCOME) EXPENSES, NET [Abstract]	'	'	'	'
Israeli CPI linkage difference on principal of loans from stockholders	$14,382	$9,849	$24,934	$201,280
Exchange rate differences	94,815	18,147	-4,638	346,859
Warrants with down-round protection	6,251,242	-35,892	'	6,215,350
Issuance cost allocated to warrants with down-round protection	390,928	'	'	390,928
Stock-based interest compensation to holders of convertible notes	'	'	'	1,214,943
Interest expenses on credit from banks and other	17,592	6,605	10,597	-1,521
Interest expenses and other, related to convertible notes	'	'	'	200,812
Financing expenses, net	$6,768,959	($1,291)	$30,893	$8,568,651

INCOME_TAX_Reconciliation_of_S

INCOME TAX (Reconciliation of Statutory Tax Rate to the Effective Income Tax Rate) (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
INCOME TAX [Abstract]	'	'	'
Pretax loss	($9,796,853)	($2,772,307)	($2,364,339)
Federal tax rate	35.00%	35.00%	35.00%
Tax expense reported in the financial statements:	'	'	'
Income tax benefit computed at the ordinary tax rate	-3,428,899	-970,307	-827,519
Non-deductible expenses	21,250	4,553	4,885
Stock-based compensation	10,570	122,333	132,325
Amortization of warrants with down round protection	2,324,760	'	'
Tax in respect of differences in corporate tax rates	253,942	277,231	236,434
Losses and timing differences in respect of which no deferred taxes assets were recognized	818,377	566,190	453,875
Tax expense reported in the financial statements	'	'	'

INCOME_TAX_Deferred_Taxes_Deta

INCOME TAX (Deferred Taxes) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Composition of deferred tax assets:	'	'	'
Provision for employee-related obligation	$33,629	$47,440	$42,137
Non-capital loss carry forwards	4,364,466	3,496,123	2,890,426
Valuation allowance	-4,398,095	-3,543,563	-2,932,563
Total deferred taxes	'	'	'
Parent Company [Member]	'	'	'
Carryforward tax losses	'	'	'
Loss carry forward balances	1,400,000	'	'
A.D. Integrity Applications Ltd. [Member]	'	'	'
Carryforward tax losses	'	'	'
Loss carry forward balances	$15,500,000	'	'

LOSS_PER_SHARE_Details

LOSS PER SHARE (Details) (USD $)

12 Months Ended

15 Months Ended

147 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2010

Dec. 31, 2009

Dec. 31, 2008

Dec. 31, 2007

Dec. 31, 2006

Dec. 31, 2005

Dec. 31, 2004

Dec. 31, 2003

Dec. 31, 2002

Dec. 31, 2013

LOSS PER SHARE [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

Loss for the year

$9,796,853

$2,772,307

$2,364,339

$2,788,446

$1,202,296

$1,528,981

$1,593,205

$1,282,842

$1,055,594

$288,233

$350,290

$63,293

$25,086,679

Stock dividend to certain Common Stockholder

278,263

'

'

'

'

'

'

'

'

'

'

'

'

Dividend on Preferred Stock

288,247

'

'

'

'

'

'

'

'

'

'

'

'

Loss for the period attributable to common stockholders

$10,363,363

$2,772,307

$2,364,339

'

'

'

'

'

'

'

'

'

'

Number of shares:

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted average number of shares used in the computation of basic and diluted earnings per share

5,325,714

5,314,800

5,091,330

'

'

'

'

'

'

'

'

'

'

Total weighted average number of ordinary shares related to outstanding options and warrants excluded from the calculations of diluted loss per share

2,813,493

[1]

600,232

[1]

582,732

[1]

'

'

'

'

'

'

'

'

'

'

[1]

All outstanding stock options, warrants and Preferred Stock have been excluded from the calculation of the diluted net loss per share for all the reported periods, since the effect of the shares issuable with respect of these instruments was anti-dilutive.

RELATED_PARTIES_Details

RELATED PARTIES (Details)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013
	Avner Gal [Member]	Avner Gal [Member]	David Malka [Member]	David Malka [Member]
	USD ($)	ILS	USD ($)	ILS
Related Party Transaction [Line Items]	'	'	'	'
Ownership percentage	10.71%	10.71%	4.45%	4.45%
Amount of related party transaction	$138,500	480,000	$69,150	240,000